Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AJM1	"ajm-1, C9orf172"	ENSG00000232434	"Apical junction component 1 homolog"	C9J069	9	136844415-136848801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;testis: 15.0"	"Cell type enhanced"	"Detected in some"	23	"Collecting duct cells: 5.2;Ductal cells: 1.4;granulocytes: 1.1;Pancreatic endocrine cells: 1.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 22.7"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.9;monocytes: 1.6;T-cells: 1.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA021200	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"		"HPA021200: AB_10601695"	"unprognostic (3.30e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.68e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.00e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.07e-3)"	"unprognostic (7.27e-2)"	1.1	1.9	4.6	1.3	6.3	1.4	1.1	22.7	7.9	1.1	4.0	1.1	1.1	3.3	1.2	1.1	1.1	0.3	1.1	1.2	4.4	3.1	1.1	1.1	1.1	1.1	2.1	1.1	1.1	7.6	1.1	5.2	1.1	1.1	2.6	1.1	1.1	2.0	2.2	3.9	1.5	4.3	1.1	1.3	3.6	2.3	15.0	1.1	1.1	1.1	1.1	1.1	2.6	1.1	0.2	3.9	0.1	1.6	0.2	1.9	0.8	3.7	3.0	0.4	1.1	0.5	0.4	4.9	3.0	0.5	0.4	0.2	1.0	2.0	2.3	2.6	0.8	1.0	4.2	0.4	1.1	0.0	5.8	2.2	0.6	5.6	0.9	1.7	1.3	4.2	0.9	1.5	0.5	0.3	2.5	0.2	1.1	3.5	1.5	0.7	4.1	0.4	4.5	1.2	3.1	3.9	2.8	0.9	7.3	0.9	0.7	7.4	2.6	1.9	7.6	4.0	0.6	6.0	2.8	3.1	5.0	3.5	1.7	1.8	6.6	4.5	0.8	8.8	4.6	1.2	0.0	1.6	0.1	1.9	1.0	0.4	0.2	0.5	0.9	1.5	0.0	0.2	0.9	0.1	0.2	1.5	3.9	0.1	0.8	4.6	6.3	22.7	6.8	4.4	3.1	2.1	1.1	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AL132780.3		ENSG00000259132			14	22946270-22982258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"Alveolar cells type 1: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 28.1"									HPA029803	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA029803: AB_10601428"																		4.8	6.2	4.5	4.7	5.5	6.6	5.3	3.5	2.4	16.1	7.1	2.3	7.1	5.5	12.4	9.2	16.2	6.6	11.2	6.0	4.6	3.8	20.4	24.5	10.5	7.9	5.3	1.9	11.8	13.8	0.0	3.5	18.1	3.8	13.1	6.1	10.4	5.7	16.0	6.2	8.8	4.5	3.5	4.5	11.3	4.5	6.0	1.9	10.3	22.1	7.7	9.6	5.0	7.9	3.3	5.7	10.2	5.9	1.1	4.1	2.8	4.1	8.9	6.2	2.0	6.1	7.2	4.0	0.7	5.8	3.7	3.8	3.0	3.1	0.0	2.4	6.8	2.1	1.6	2.9	3.1	2.6	0.0	0.7	1.3	6.8	28.1	4.0	3.2	2.6	3.2	8.2	2.9	7.0	8.1	5.1	7.4	0.0	6.1	4.0	16.8	7.0	12.0	3.0	6.9	1.9	3.4	4.4	3.8	10.3	8.4	3.5	2.0	2.8	3.6	1.7	4.5	5.5	7.1	1.0	4.7	3.4	1.9	3.5	6.0	7.3	6.3	1.6	3.2	2.9	0.5	5.9	2.1	2.5	4.2	1.2	2.7	1.8	2.1	5.7	3.3	3.4	1.7	10.2	1.1	2.9	2.6	4.1	2.8	4.5	5.5	3.5	2.4	4.6	3.8	5.3	1.9	3.8	1.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALKBH6	MGC15677	ENSG00000239382	"AlkB homolog 6"	Q3KRA9	19	36009120-36014239	"Cancer-related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073835, HPA074340"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA073835: AB_2686637, HPA074340: AB_2686680"	"unprognostic (1.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.86e-5)"	"unprognostic (6.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-2)"	"unprognostic (8.78e-4)"	"unprognostic (1.77e-2)"	"unprognostic (2.31e-5)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.05e-3)"	8.4	7.0	14.1	6.4	15.2	6.8	6.3	7.8	18.9	5.8	8.2	7.8	2.5	6.6	6.5	6.6	6.5	8.2	7.7	9.2	13.0	14.9	5.7	12.6	6.8	8.7	14.8	12.5	5.4	3.4	8.2	8.5	6.2	19.5	9.7	4.6	6.5	8.7	9.9	6.3	5.8	6.4	8.5	10.5	8.9	9.6	4.2	4.9	5.7	6.2	3.7	8.4	7.2	4.7	18.1	13.5	29.5	15.0	15.7	19.5	9.4	10.3	11.1	4.2	6.2	6.6	4.0	7.1	10.3	6.9	12.1	12.3	4.6	5.5	9.1	16.5	5.7	6.3	4.1	4.4	11.9	6.4	14.3	8.0	5.2	4.2	4.9	7.5	4.5	16.0	6.0	8.6	10.0	3.4	4.2	8.2	13.9	8.1	6.9	6.5	10.8	10.8	5.9	3.3	10.8	7.2	6.9	5.8	6.5	8.7	4.6	5.1	5.3	7.0	8.5	8.6	6.2	6.7	10.2	3.5	6.3	9.3	14.3	10.0	13.0	7.7	6.4	13.7	5.1	6.7	29.5	11.4	27.3	17.1	15.0	13.0	18.1	15.5	16.1	9.6	14.6	13.2	12.8	9.6	15.7	11.7	13.5	19.5	9.4	14.1	15.2	7.8	18.9	13.0	14.9	14.8	12.5	19.5	4.9	3.0	1.7	11.5	10.4	6.1	6.0	1.4	10.2	0.0	1.2	17.4	0.0	16.3	5.0	9.6	4.7	4.7	7.7	23.3	8.1	13.8	6.9	7.1	0.0	12.9	9.3	9.5	12.6	8.0	4.9	4.0	10.3	7.9	8.5	19.8	9.6	4.9	10.7	14.0	4.2	8.7	3.3	6.5	9.6	3.1	2.5	4.4	15.9	15.8	8.0	8.8
ARAP2	"CENTD1, PARX"	ENSG00000047365	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2"	Q8WZ64	4	35948221-36244509	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 142.9;Early spermatids: 113.2;Late spermatids: 89.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.0;hTCEpi: 11.3;MOLT-4: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035925	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Actin filaments"	"HPA035925: AB_10672075"	"unprognostic (2.97e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.48e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	5.2	2.5	16.3	9.1	27.5	32.5	5.2	4.8	20.8	4.2	5.1	18.3	0.3	8.5	3.5	4.1	12.7	3.5	9.2	2.5	16.0	9.5	3.9	8.8	12.7	13.7	24.4	12.1	1.9	6.8	8.2	5.1	3.5	18.4	2.9	5.8	0.7	5.8	3.3	1.4	16.1	8.2	4.4	15.3	10.4	5.8	5.9	32.0	26.4	22.4	4.0	10.2	6.2	7.2	2.4	1.7	0.6	5.8	8.6	5.7	0.7	7.3	0.6	0.7	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.6	12.0	3.5	2.9	0.3	0.0	2.8	1.1	5.8	0.0	0.0	6.6	0.1	2.4	0.2	1.5	4.6	0.0	0.4	11.3	0.0	2.5	4.4	0.0	9.7	0.2	0.6	0.0	3.1	10.7	3.8	0.8	5.1	2.3	5.5	0.0	4.0	8.3	7.5	6.5	0.0	0.4	1.8	2.4	0.4	5.0	1.4	0.0	2.0	6.7	0.0	1.0	0.0	0.0	6.8	0.8	5.3	1.7	0.0	0.8	0.0	5.7	2.7	5.3	2.4	3.2	3.9	0.4	1.4	1.1	2.9	0.6	8.6	5.8	1.7	1.5	0.7	16.3	27.5	4.8	20.8	16.0	9.5	24.4	12.1	18.4	32.0	142.9	21.8	22.6	24.0	34.8	0.3	1.7	10.2	20.1	43.3	7.0	0.0	0.1	6.6	7.2	113.2	13.5	14.6	0.0	8.6	0.2	4.5	28.3	9.2	3.8	7.3	0.0	2.9	3.1	32.3	89.9	2.6	17.8	5.0	16.2	9.2	5.4	15.9	17.5	0.7	4.1	1.0	0.0	1.4	3.2	1.9	59.0	0.7	42.4	6.4	46.4
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.8;lymphoid tissue: 48.4"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 71.1;Kupffer cells: 73.8;Macrophages: 43.6;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.2;Karpas-707: 26.9;MOLT-4: 25.3;RPMI-8226: 49.8;THP-1: 24.3;U-698: 23.2;U-937: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001012, HPA001083"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Nucleoplasm	"HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favorable (3.94e-5)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	7.0	4.8	5.3	24.3	5.8	44.8	5.0	4.5	3.2	3.1	6.5	5.2	2.1	6.0	3.9	7.0	4.4	5.2	6.5	4.2	4.5	3.2	7.4	4.9	13.4	29.1	5.2	0.9	2.6	2.3	0.9	3.5	9.0	4.8	4.2	3.0	5.7	7.5	1.8	1.6	1.8	18.0	3.9	5.9	48.4	4.9	3.6	4.2	43.2	4.2	1.6	29.0	7.1	3.6	10.8	17.7	18.7	30.5	8.5	15.7	12.6	0.4	0.1	0.2	1.7	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.1	12.5	26.2	1.6	0.0	0.2	0.2	1.3	0.0	0.0	7.1	1.0	10.2	0.1	0.5	1.1	18.6	17.3	0.0	0.1	0.0	0.1	0.1	2.6	6.6	0.0	26.9	0.1	1.3	25.3	0.3	0.8	0.1	0.0	12.0	3.5	49.8	0.1	0.2	2.4	3.6	0.2	0.6	0.2	0.3	5.9	24.3	0.5	0.1	0.3	0.2	0.1	16.3	13.9	23.2	0.2	21.7	0.0	5.1	14.1	18.7	15.7	23.1	10.9	10.8	11.2	12.4	14.1	10.4	10.1	10.1	12.0	8.5	30.5	17.7	12.6	12.6	5.3	5.8	4.5	3.2	4.5	3.2	5.2	0.9	4.8	4.2	8.9	33.9	40.2	0.5	3.1	9.8	30.4	2.5	13.4	4.5	17.4	3.9	1.7	5.0	0.7	0.1	10.6	3.9	0.0	0.6	1.2	2.1	0.4	33.5	0.5	71.1	3.2	4.6	4.3	73.8	0.0	0.9	43.6	10.1	12.6	2.1	1.3	0.1	0.0	0.0	0.6	4.4	0.0	0.9	0.5	4.9	1.5	1.1	48.4	3.9	0.4
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.0;salivary gland: 35.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 42.2;Ciliated cells: 72.3;Mucus-secreting cells: 62.9;Undifferentiated cells: 69.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.5;OE19: 26.0;RT4: 11.4;SK-BR-3: 20.2;T-47d: 6.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.3	0.0	2.1	8.0	1.5	6.1	2.5	0.2	2.0	3.5	23.0	0.5	1.9	16.3	1.8	1.9	2.7	4.0	18.8	0.4	1.8	1.9	2.6	0.2	21.9	0.2	1.3	0.7	1.3	0.5	0.0	2.9	4.8	0.7	7.9	21.9	1.0	35.8	0.2	0.9	15.2	14.5	0.5	0.6	0.2	3.4	0.4	0.4	0.3	8.2	2.2	8.1	4.8	7.8	0.0	0.0	2.7	0.0	0.0	0.1	0.0	3.6	0.2	0.4	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	3.4	3.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	26.0	0.1	0.0	0.0	0.1	0.0	11.4	2.9	0.0	0.0	20.2	0.1	0.5	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	2.0	1.8	1.9	1.3	0.7	0.7	0.4	29.8	42.2	0.0	12.3	0.6	1.4	0.6	2.5	72.3	29.6	0.0	0.0	1.9	0.0	7.2	3.0	0.6	15.4	0.0	2.3	2.2	0.3	21.6	9.2	0.0	0.2	0.0	32.8	0.0	0.0	1.1	0.0	0.7	1.7	0.0	62.9	1.3	3.1	17.3	0.0	1.9	5.6	0.0	0.5	0.7	0.6	1.0	20.1	0.0	69.5	9.5
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 27.1;Cholangiocytes: 50.9;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	7	"basophil: 24.5;NK-cell: 12.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.5;NK-cells: 12.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 17.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hippocampal formation: 3.6"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Nucleoplasm	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.6	0.4	0.2	4.7	0.2	0.2	0.7	0.2	0.3	4.2	4.1	0.1	5.6	1.2	1.1	1.0	1.2	3.6	21.0	0.7	1.0	0.4	7.1	21.8	2.0	1.8	0.2	0.1	0.4	5.0	0.2	0.7	0.5	2.4	2.2	0.7	0.4	34.3	3.0	0.3	4.5	1.9	0.5	0.4	4.9	1.6	0.6	0.1	0.4	0.4	1.6	5.2	1.5	1.0	1.7	0.0	24.5	0.0	12.7	2.6	0.7	0.2	1.8	0.1	0.0	0.3	0.1	2.2	0.1	0.0	0.0	0.1	3.2	0.1	0.7	0.1	0.0	0.3	1.3	0.0	0.8	0.0	0.1	0.0	0.3	0.7	0.9	0.0	0.0	17.6	0.8	2.5	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.1	0.4	0.1	0.4	0.1	1.4	0.0	0.0	0.1	0.0	0.4	0.9	0.7	0.0	0.1	0.0	0.7	24.5	0.0	1.8	2.6	0.0	2.5	1.5	0.7	1.3	0.0	1.7	0.0	0.6	0.4	12.7	0.0	0.0	0.5	0.7	0.2	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.4	0.1	11.9	27.1	15.9	8.0	8.4	1.2	0.6	50.9	5.3	5.7	5.2	0.0	1.5	0.0	9.1	0.4	1.8	4.2	0.0	6.3	8.2	1.1	2.3	4.7	12.7	0.9	0.0	3.5	1.3	1.0	0.2	0.6	2.0	3.3	0.0	18.8	1.7	4.0	3.5	0.4	16.5	0.6	0.0	1.7	0.3	2.4	8.3	2.4	25.4	16.4	4.3
CHRNA5		ENSG00000169684	"Cholinergic receptor nicotinic alpha 5 subunit"	P30532	15	78565520-78595269	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 33.9"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 9.6;Spermatogonia: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054381	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Plasma membrane"	"HPA054381: AB_2682468"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.20e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.03e-5)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.50e-11)"	"unprognostic (4.37e-1)"	"unprognostic (5.39e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	2.9	3.3	1.7	4.4	1.7	0.6	4.9	1.8	1.7	2.7	6.4	0.4	1.6	7.8	4.7	1.9	4.0	1.1	16.3	2.4	1.7	1.8	0.9	1.8	1.4	2.0	1.9	0.3	1.7	11.8	0.0	0.7	2.1	1.2	3.6	7.1	3.5	1.7	0.7	5.8	1.0	6.8	6.1	1.3	1.9	5.3	9.8	0.6	4.5	1.6	2.9	4.4	5.7	33.9	0.9	1.1	3.4	1.6	1.6	1.4	0.7	6.7	17.4	9.5	5.2	1.1	0.8	3.8	4.9	2.4	5.5	10.0	6.6	32.1	4.0	12.2	1.0	14.8	6.0	18.1	7.3	5.6	8.1	21.7	7.4	13.6	6.6	0.6	5.0	10.5	0.3	1.3	1.5	2.0	2.0	10.2	5.6	7.2	5.2	3.5	14.7	6.3	1.7	7.7	13.3	4.8	8.1	10.9	4.0	6.6	16.1	16.0	23.5	11.9	11.6	5.5	5.6	25.8	1.3	2.2	7.5	9.0	5.5	15.5	6.1	25.0	4.5	4.5	8.1	6.9	3.0	1.6	2.5	0.8	1.6	0.4	0.3	0.8	0.5	0.9	0.9	1.4	1.4	3.4	1.6	1.3	1.1	0.3	0.7	1.7	1.7	1.8	1.7	1.7	1.8	1.9	0.3	1.2	0.6	0.0	0.0	0.0	7.8	2.9	1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	1.0	1.0	0.0	0.0	1.8	9.6	0.4	5.2	0.0	0.0	0.9	4.8	3.4	0.0	0.0	1.2	0.3	0.8	1.7	0.0	6.3	0.2	0.7	0.0	0.4	0.2	0.5	0.0	2.1	3.2	32.1	1.4	0.8	1.3	1.5	2.7
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578969-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.5;fallopian tube: 27.4"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 32.6;Ciliated cells: 14.7;Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 20.9"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.2;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	21	"B-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.9;ASC TERT1: 27.8;HSkMC: 20.0;hTEC/SVTERT24-B: 16.3;U-87 MG: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced	Supported	Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	4.4	15.7	3.2	30.1	1.9	4.8	33.7	53.5	6.5	3.4	27.3	0.8	2.4	7.5	3.9	2.7	27.4	6.3	7.2	23.0	15.1	5.5	2.0	5.8	3.5	20.9	18.8	18.4	2.9	1.6	1.5	4.7	23.6	3.2	2.9	11.8	3.4	6.9	3.8	5.6	3.3	8.4	35.0	3.6	2.0	2.2	17.5	0.0	4.6	0.6	1.9	3.0	1.6	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	12.3	1.0	12.9	27.8	0.0	6.2	6.9	1.1	1.5	0.1	1.4	1.5	0.7	1.0	1.7	0.0	0.4	0.1	4.5	0.0	0.5	0.0	0.0	0.6	4.7	0.0	0.1	20.0	0.1	16.3	1.0	9.7	0.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	3.0	0.0	0.0	1.0	0.0	0.5	1.7	0.0	7.1	0.1	0.1	0.0	3.6	2.4	0.0	1.4	0.1	3.7	4.1	0.7	8.2	0.0	0.0	1.5	27.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	30.1	33.7	29.3	23.0	15.1	20.9	18.8	23.6	17.5	0.0	0.0	0.0	0.3	0.9	32.6	1.1	0.0	14.7	0.0	7.0	35.3	0.0	0.0	3.8	0.2	1.5	0.0	0.0	0.5	0.0	2.6	0.1	0.0	0.0	0.2	0.0	3.5	5.5	0.3	0.0	7.2	0.0	6.8	0.0	0.0	9.5	0.4	0.0	0.4	0.0	20.9	6.5	2.3	0.2	0.4	0.6	0.0	0.0	0.0	0.1
CUTA	"ACHAP, C6orf82"	ENSG00000112514	"CutA divalent cation tolerance homolog"	O60888	6	33416442-33418317	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016787, HPA064369"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA		35000000	"Plasma membrane, Focal adhesion sites"		"CAB016787: , HPA064369: AB_2685248"	"unprognostic (7.03e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.98e-2)"	"prognostic favorable (8.50e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.55e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.74e-1)"	26.6	65.6	47.9	28.3	60.1	33.5	47.6	37.7	73.7	47.7	37.9	36.8	53.9	42.1	40.1	78.5	30.5	46.0	48.8	49.6	45.2	44.9	46.3	61.6	39.0	77.4	46.5	37.8	57.7	66.6	43.8	86.1	45.7	39.8	38.8	28.9	34.2	74.3	69.7	34.6	32.7	37.2	32.4	47.0	36.0	38.7	27.3	31.6	52.2	69.7	30.3	31.3	42.6	28.9	56.5	31.4	27.1	32.0	49.9	69.8	60.8	43.8	26.3	42.1	53.3	31.7	31.2	20.4	40.1	75.1	77.6	82.7	26.2	27.4	31.0	31.2	45.9	56.4	26.8	27.3	40.8	43.8	26.2	60.5	32.3	43.6	68.6	41.3	25.1	24.6	41.3	34.5	37.3	31.5	54.0	20.8	32.9	39.6	63.1	56.7	34.1	38.0	53.5	37.7	38.0	34.7	41.8	25.1	81.9	53.4	19.1	82.4	42.0	24.0	41.8	72.8	25.2	30.7	52.8	22.9	42.0	35.7	29.8	41.8	62.0	61.6	33.9	36.3	55.6	34.1	27.1	32.0	16.5	45.7	22.9	63.2	56.5	67.6	52.7	31.4	44.2	68.5	53.2	4.6	49.9	16.8	27.1	69.8	60.8	47.9	60.1	37.7	73.7	45.2	44.9	46.5	37.8	39.8	31.6	122.1	105.5	178.5	242.5	204.8	84.5	113.4	239.5	131.2	121.7	300.1	64.8	309.8	240.4	162.1	64.8	93.9	157.7	23.3	122.9	203.5	204.8	237.5	167.3	299.7	277.3	73.1	280.4	131.3	162.9	285.6	185.2	150.2	300.3	80.2	266.0	150.8	114.3	196.4	180.0	440.5	69.0	90.5	220.1	100.6	65.6	201.4	203.1	245.2	291.8	203.9
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.9"	"Group enriched"	"Detected in all"	4	"Cardiomyocytes: 200.2;Early spermatids: 375.8;Late spermatids: 573.8;monocytes: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Nucleoplasm, Focal adhesion sites"		"HPA054305: AB_2682444"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	10.6	17.0	10.9	7.8	12.2	6.2	8.8	10.5	17.8	10.2	11.5	3.9	8.4	6.2	9.5	11.4	9.3	7.7	8.2	43.8	7.6	5.5	9.5	26.2	7.3	4.8	5.2	11.5	8.3	6.1	10.8	11.3	7.8	6.5	10.5	8.7	5.7	10.3	11.9	155.9	6.4	7.8	10.2	4.8	5.9	9.8	21.5	4.8	7.8	8.2	27.3	7.3	9.1	7.3	6.2	7.7	12.5	13.9	4.4	7.2	5.0	23.0	11.0	6.1	9.9	20.3	28.9	21.6	23.6	35.4	16.8	25.1	18.3	19.5	19.1	13.8	30.5	8.0	17.4	9.6	17.7	23.8	10.8	10.2	20.3	16.8	13.1	16.4	9.1	9.7	20.5	17.9	15.9	13.3	25.6	18.3	6.1	22.9	15.8	24.7	5.3	10.1	8.3	3.9	12.9	12.3	7.8	12.7	14.8	41.9	11.3	9.0	7.2	18.9	17.4	12.9	13.4	29.7	11.2	25.8	16.8	10.5	16.2	9.7	17.0	13.8	14.9	22.4	7.8	6.8	6.0	7.0	12.5	6.7	9.6	7.2	6.2	5.4	5.8	7.7	4.5	5.0	6.4	7.2	4.4	13.9	4.6	6.1	5.0	10.9	12.2	10.5	17.8	7.6	5.5	5.2	11.5	6.5	4.8	53.6	33.4	19.8	24.8	51.4	13.4	200.2	45.9	60.2	53.4	24.4	21.6	61.0	14.9	25.7	375.8	29.8	24.8	46.7	16.9	26.6	39.2	32.0	18.5	81.0	17.8	4.8	20.3	25.8	28.6	573.8	53.2	22.6	35.4	176.7	27.3	14.6	18.0	28.1	45.6	26.9	16.7	32.3	37.1	78.4	58.9	34.8	68.0	20.8	28.8	23.7
DOK6	"DOK5L, HsT3226, MGC20785"	ENSG00000206052	"Docking protein 6"	Q6PKX4	18	69401055-69849087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 239.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.4;Hep G2: 10.9;RPMI-8226: 10.5;SCLC-21H: 4.8;SH-SY5Y: 10.9;SuSa: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041099, HPA063534"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"		"HPA041099: AB_2677299, HPA063534: AB_2685032"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.62e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.13e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.09e-3)"	2.1	1.6	21.3	1.6	11.3	0.6	1.3	6.8	22.1	3.8	1.5	0.9	0.3	1.0	3.0	1.4	1.7	1.7	5.8	10.2	19.2	9.2	8.7	4.4	4.2	1.2	13.7	13.1	4.2	0.7	3.4	1.1	9.9	14.0	3.5	1.3	5.5	1.7	4.2	0.6	1.2	1.3	6.6	2.7	1.8	1.3	2.8	2.7	0.0	4.1	0.0	1.2	5.2	6.6	0.0	0.0	0.0	0.0	0.9	0.9	0.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	10.9	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.5	0.0	0.0	4.8	10.9	0.0	0.0	0.0	8.1	0.0	0.0	0.0	4.1	0.6	0.0	1.5	0.3	0.0	0.0	3.1	0.0	3.2	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.0	0.9	0.0	0.0	0.3	0.4	21.3	11.3	6.8	17.1	19.2	9.2	13.7	13.1	14.0	2.7	0.0	0.0	0.0	0.1	0.2	239.6	6.5	0.0	0.0	2.3	0.0	13.7	0.0	1.7	0.0	32.5	0.7	0.0	0.0	0.0	0.0	5.3	0.1	0.0	1.0	0.0	9.5	0.0	0.0	0.3	23.0	1.4	0.3	0.0	0.0	0.0	4.1	0.0	0.0	6.3	7.8	12.7	0.0	2.7	0.7	0.1	0.5	0.0	0.0	0.0	0.1
EXD3	"FLJ20433, LOC54932, mut-7"	ENSG00000187609	"Exonuclease 3'-5' domain containing 3"	Q8N9H8	9	137306896-137423262	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"granulocytes: 63.2;Late spermatids: 57.2;Paneth cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 21.6"					"Low region specificity"	"Detected in all"			HPA047395	Approved		Approved	"Actin filaments,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Actin filaments"	"HPA047395: AB_10962864"	"unprognostic (2.91e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.75e-3)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.05e-2)"	9.7	10.9	8.0	10.1	11.1	8.4	10.4	11.9	12.4	11.2	15.5	16.5	14.9	22.8	10.2	17.5	11.1	11.5	14.1	10.5	8.7	7.9	11.8	7.3	12.3	8.0	9.5	11.2	11.1	13.3	8.3	13.8	8.3	11.0	14.0	8.9	13.9	17.5	11.4	15.9	17.4	20.6	15.8	7.4	16.3	14.3	5.1	9.1	1.7	11.4	6.8	7.8	10.0	10.8	4.0	5.3	10.8	6.0	5.3	8.5	3.6	5.7	4.9	2.4	6.8	2.0	3.0	5.7	2.9	3.3	2.5	3.9	3.3	12.4	2.5	7.9	2.1	6.3	10.7	0.7	3.1	0.8	5.8	5.9	2.0	8.7	5.1	6.2	1.4	21.6	3.4	4.3	2.2	1.9	7.3	8.6	0.0	4.7	4.6	2.1	15.4	0.1	4.9	2.8	12.6	3.4	4.4	2.0	17.2	5.1	3.3	3.3	6.0	2.8	6.0	2.7	2.9	9.7	6.4	10.7	3.5	3.4	5.5	4.3	6.1	2.7	2.1	6.7	4.5	6.6	10.8	5.0	10.6	3.5	6.0	4.0	3.9	6.0	3.3	5.3	4.0	4.8	3.7	1.2	5.3	5.8	3.4	8.5	3.6	8.0	11.1	11.9	12.4	8.7	7.9	9.5	11.2	11.0	9.1	0.0	4.6	0.5	9.4	5.3	13.3	4.5	5.1	5.3	6.8	7.0	13.7	8.3	8.3	6.2	13.5	11.3	39.9	0.0	9.8	2.8	5.3	8.7	63.2	5.5	7.6	20.6	7.0	16.5	4.9	57.2	5.5	5.1	3.3	2.8	22.2	8.6	6.3	178.5	7.4	10.3	10.3	12.9	7.1	2.8	9.4	7.9	3.3	6.9	28.5	7.4
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114087-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003289			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA003289: AB_2666879"	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	17.4	13.1	16.4	14.9	19.7	12.1	19.6	22.5	21.6	18.7	15.9	15.0	13.1	13.3	16.2	13.3	22.2	14.1	15.1	15.0	15.3	15.6	21.4	26.6	14.0	14.9	15.9	13.6	18.7	13.4	25.7	16.2	15.8	20.2	16.5	17.1	11.9	16.6	14.9	24.6	32.3	14.4	15.7	15.6	16.1	13.7	11.9	15.5	19.4	15.7	13.1	16.1	17.5	20.0	10.3	10.0	14.7	8.9	10.9	11.0	5.7	14.1	6.3	9.8	10.4	10.3	11.8	16.1	14.3	11.7	9.7	9.3	8.6	11.1	6.8	14.8	13.0	6.2	12.5	14.4	13.9	16.8	9.6	16.1	8.6	7.9	6.2	12.8	16.3	11.4	11.5	16.8	14.0	25.6	11.4	16.1	8.9	14.1	9.8	17.4	4.6	8.4	8.3	23.3	18.8	13.5	9.0	14.0	12.8	18.3	9.4	15.9	17.0	14.9	22.9	15.9	10.7	12.1	16.4	18.4	12.1	9.2	15.1	26.9	10.7	12.6	10.7	15.0	8.0	23.4	8.9	8.7	14.7	7.8	8.1	10.1	10.3	8.2	9.6	10.0	10.2	8.3	9.1	5.3	10.9	8.9	4.7	11.0	5.7	16.4	19.7	22.5	21.6	15.3	15.6	15.9	13.6	20.2	15.5	6.0	8.8	12.3	21.3	30.5	18.7	10.6	7.6	6.7	11.4	10.4	21.6	12.1	8.3	10.9	19.1	14.2	10.6	23.3	9.8	11.5	11.0	18.7	13.9	22.2	12.3	17.5	17.7	9.8	16.3	11.5	12.0	13.9	27.0	10.8	14.0	10.1	13.4	10.5	12.4	17.9	18.4	12.9	11.3	26.0	26.5	34.3	19.2	17.5	11.9	27.2
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 312.0;ovary: 80.7"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 732.1;Extravillous trophoblasts: 503.8;Leydig cells: 525.0;Peritubular cells: 986.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 79.9;RPTEC TERT1: 73.7"	"Group enriched"	"Detected in many"	4	"amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3"	"Low region specificity"	"Detected in many"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"		NA	Yes			"Actin filaments, Focal adhesion sites"		"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	8.3	9.8	1.5	5.7	3.6	1.5	8.9	0.8	5.6	16.3	10.5	1.4	5.1	6.0	14.8	12.1	9.2	6.8	16.5	312.0	2.5	0.4	5.5	7.8	2.1	2.7	0.9	3.0	80.7	1.6	0.2	4.1	16.7	1.1	12.8	7.4	18.5	6.2	8.7	9.4	5.6	16.9	11.9	0.8	3.9	12.7	13.4	0.7	3.1	6.6	16.9	5.1	18.1	7.6	1.4	1.3	7.8	0.8	1.5	4.6	2.6	22.5	5.3	3.1	0.1	10.1	12.8	29.6	42.8	11.3	27.5	33.1	9.5	35.3	0.0	3.6	52.1	34.0	7.0	4.6	38.9	31.4	0.9	3.5	15.8	6.5	7.1	40.0	0.0	3.5	26.6	21.4	43.2	28.8	55.2	56.0	2.6	4.1	1.3	79.9	0.8	3.6	0.1	6.5	15.8	16.7	0.0	4.8	0.6	73.7	16.0	0.1	1.0	16.0	7.2	11.1	3.2	9.0	0.5	26.9	20.0	20.3	22.1	34.4	0.4	0.0	0.1	31.9	0.0	20.6	7.8	0.8	1.0	2.2	0.4	1.5	1.1	1.8	3.6	0.7	1.4	1.4	2.9	4.5	1.5	0.3	1.3	4.6	2.6	1.5	3.6	0.8	5.6	2.5	0.4	0.9	3.0	1.1	0.7	8.9	6.1	0.0	732.1	416.1	8.9	221.1	15.3	12.0	54.6	27.9	2.0	150.7	3.3	97.9	3.5	21.5	61.9	0.0	105.2	503.8	71.2	120.1	10.3	9.2	22.4	0.0	55.8	20.9	1.2	4.9	525.0	6.6	21.9	4.6	119.3	1.5	144.0	32.8	986.1	15.3	12.4	213.4	132.8	6.6	21.1	259.6	149.4	5.0	30.8	351.4
HAUS4	"C14orf94, FLJ20424"	ENSG00000092036	"HAUS augmin like complex subunit 4"	Q9H6D7	14	22946228-22957161	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA029803, HPA071195"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA029803: AB_10601428, HPA071195: "	"unprognostic (8.47e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.47e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.24e-4)"	17.2	16.7	11.0	28.8	15.0	29.8	22.3	9.9	15.6	20.3	24.0	13.8	22.3	15.3	17.8	20.7	25.4	16.9	30.6	19.5	12.3	8.3	16.8	17.9	24.0	30.6	17.7	9.2	33.8	29.1	17.5	9.8	12.1	13.4	19.1	16.9	14.2	22.0	19.2	14.4	21.7	24.9	23.3	17.6	24.5	19.3	12.2	17.4	33.7	23.2	17.2	21.2	18.9	19.5	14.0	35.3	34.5	28.2	7.8	15.4	15.3	25.8	17.6	20.4	20.1	15.0	18.8	30.6	13.0	17.4	14.2	20.0	12.6	30.9	50.0	6.2	7.8	10.5	26.1	10.8	15.5	12.0	13.4	8.1	16.8	12.4	30.7	13.7	21.5	28.0	12.8	30.1	6.1	18.6	17.7	24.7	29.2	11.7	25.0	15.2	19.9	23.5	19.1	10.7	20.6	17.9	22.5	24.5	19.2	12.3	14.2	8.2	13.3	18.6	19.3	11.4	9.2	16.8	17.4	13.6	13.0	16.8	9.4	11.4	26.5	22.7	23.2	6.1	24.4	7.4	2.1	28.2	5.8	5.8	18.3	7.8	14.0	10.9	8.3	35.3	11.6	15.4	11.8	34.5	7.8	11.3	9.9	14.6	15.3	11.0	15.0	9.9	15.6	12.3	8.3	17.7	9.2	13.4	17.4	20.8	5.0	11.0	5.1	11.0	0.4	0.8	20.4	10.7	5.7	1.8	0.0	10.2	5.0	13.0	0.2	5.8	8.7	0.0	23.7	11.7	5.8	2.6	3.5	3.9	15.2	0.0	7.5	7.4	24.9	0.0	5.2	13.2	5.0	42.3	17.3	3.9	20.7	17.5	3.9	4.9	0.3	0.0	5.2	2.5	5.4	9.7	6.9	7.9	30.1	5.4
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.8;testis: 45.2"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 118.4;Spermatogonia: 74.4;T-cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 25.7;MOLT-4: 23.6;NB-4: 26.4;U-937: 34.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	15	"cerebellum: 18.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favorable (2.56e-4)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	3.5	2.2	6.7	5.1	10.2	7.7	5.5	3.6	11.6	6.1	4.4	4.2	1.4	3.4	2.8	3.4	1.9	1.8	4.5	3.1	9.5	10.1	1.8	1.4	4.9	9.8	8.2	5.6	3.8	1.5	0.6	3.9	3.8	10.7	2.7	6.6	1.3	2.4	2.6	2.0	2.6	5.2	2.5	6.9	8.0	3.2	45.2	2.5	10.3	1.7	1.2	7.3	5.5	1.6	5.4	10.6	18.2	12.0	22.9	28.8	15.9	5.8	3.0	0.2	0.0	0.2	0.2	0.0	1.4	0.5	3.5	0.5	8.8	9.3	0.0	3.2	2.6	0.0	0.0	0.0	0.0	2.2	1.9	0.0	15.0	11.3	0.0	3.0	8.8	13.4	2.9	0.1	0.7	0.0	0.0	0.7	25.7	0.0	6.7	0.1	14.9	23.6	26.4	8.7	4.7	1.3	10.3	0.0	0.5	0.0	6.4	14.7	0.0	12.6	3.5	0.0	0.9	0.0	19.8	0.1	0.0	11.7	6.4	0.0	4.1	5.1	0.0	0.0	34.8	0.1	16.0	8.8	18.2	28.8	10.1	26.0	5.4	14.2	26.0	10.6	2.9	11.8	21.7	8.6	22.9	12.0	8.5	13.1	15.9	6.7	10.2	3.6	11.6	9.5	10.1	8.2	5.6	10.7	2.5	0.0	0.6	0.0	1.4	1.4	3.8	1.5	17.8	1.4	1.2	5.2	0.0	10.4	3.3	2.8	8.7	2.6	3.9	0.0	1.2	16.4	3.1	0.6	6.9	0.4	14.0	0.0	4.7	6.7	11.7	17.0	4.6	8.5	1.7	7.2	2.5	2.0	1.9	6.8	2.8	0.7	2.6	6.5	2.8	118.4	74.4	1.4	4.3	38.3	5.6	2.5
HRASLS	"H-REV107, HRASLS1"	ENSG00000127252	"HRAS like suppressor"		3	193241125-193277738	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"skeletal muscle: 40.9;testis: 42.1"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 449.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;NTERA-2: 7.6;PC-3: 16.8;RH-30: 7.4;SCLC-21H: 15.3;U-2 OS: 9.3;U-251 MG: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"		No	No			"Focal adhesion sites"	Cytosol	"HPA051179: AB_2681375"	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.6	1.1	1.8	0.2	3.1	0.1	1.0	0.6	3.3	0.5	0.6	1.7	0.0	0.1	0.6	3.1	2.4	0.5	0.2	4.3	2.0	1.1	0.6	0.6	0.5	0.1	1.5	2.1	0.6	0.8	0.5	0.7	0.1	2.4	0.5	0.1	3.1	6.1	0.5	40.9	1.7	0.6	0.7	0.6	0.6	0.6	42.1	1.7	0.2	3.7	6.2	0.2	0.5	0.6	0.0	0.2	1.7	0.1	0.0	0.0	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.3	0.0	0.1	0.0	0.1	0.0	3.7	0.0	8.7	0.2	0.4	0.0	3.9	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.6	0.2	16.8	0.0	7.4	0.0	2.5	0.0	15.3	2.9	1.0	2.2	0.0	1.4	4.4	0.0	0.1	0.0	9.3	0.0	11.7	0.0	0.0	0.0	4.8	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.2	1.8	3.1	0.6	3.3	2.0	1.1	1.5	2.1	2.4	1.7	0.0	0.0	0.0	0.1	0.9	10.8	10.6	2.5	0.0	1.2	0.0	31.4	0.7	0.0	0.7	449.3	0.6	0.0	0.0	0.2	0.8	0.4	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.3	85.3	6.9	0.8	1.7	0.0	0.0	1.6	0.5	0.0	4.6	0.1	5.6	0.0	0.4	112.1	25.2	5.4	0.3	0.0	0.0	0.0
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590065-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.7;monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"RT4: 71.7;SuSa: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"		NA	NA		750000	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	23.2	22.1	17.9	18.3	21.8	3.1	25.8	16.7	23.1	22.9	13.6	23.4	11.6	8.4	26.0	11.4	14.2	14.5	25.2	40.7	16.8	12.3	51.5	9.5	20.6	7.6	24.2	11.6	35.4	18.7	65.0	11.0	29.6	22.1	16.5	11.9	83.4	17.9	15.9	13.1	21.5	10.1	29.6	33.0	12.1	17.3	11.2	17.0	7.8	33.1	10.9	11.1	17.6	17.9	0.3	0.9	7.7	2.3	0.4	1.1	0.5	9.3	11.1	7.4	23.7	27.3	18.5	28.3	18.3	14.8	6.5	6.5	9.7	32.2	0.0	36.1	20.6	22.7	11.7	3.8	17.2	9.4	1.8	3.4	2.2	14.6	13.3	10.8	1.5	1.4	13.4	8.2	14.4	12.3	39.0	15.4	1.1	2.1	4.7	17.2	3.7	0.9	1.3	5.6	5.6	5.6	0.0	15.2	1.2	16.8	71.7	1.5	4.6	21.1	6.5	7.7	62.1	5.1	4.3	46.8	40.2	12.6	8.2	15.4	1.1	1.9	1.0	16.2	0.6	19.8	7.7	1.1	1.6	1.0	2.3	0.7	0.3	0.5	0.8	0.9	0.1	0.5	0.5	0.5	0.4	1.2	0.4	1.1	0.5	17.9	21.8	16.7	17.3	16.8	12.3	24.2	11.6	22.1	17.0	26.8	18.5	2.4	54.8	114.0	118.2	124.7	73.9	12.0	20.5	73.3	72.6	46.9	1.7	78.4	0.5	50.4	13.2	0.0	89.0	21.8	61.3	83.9	49.5	15.8	26.1	14.3	7.0	34.4	33.9	1.6	17.8	18.2	43.9	20.8	18.9	82.5	120.4	18.2	24.4	16.5	54.8	32.3	47.2	0.7	1.4	90.7	33.2	6.9	11.4	48.6
LIMD1		ENSG00000144791	"LIM domains containing 1"	Q9UGP4	3	45555394-45686338	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 35.7;B-cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064220, HPA071736"	Approved		Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Nucleoplasm, Focal adhesion sites"		"HPA064220: AB_2685216, HPA071736: "	"unprognostic (2.77e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.73e-5)"	"unprognostic (8.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.61e-3)"	12.6	7.0	4.8	14.9	5.5	6.2	13.9	2.5	6.0	10.2	9.7	8.1	13.0	8.4	14.4	12.0	10.4	9.6	10.9	11.5	5.1	4.1	8.3	16.6	24.8	17.1	9.2	2.2	7.6	24.5	11.3	5.5	11.7	9.4	12.1	9.2	20.2	19.1	8.2	25.2	8.3	12.2	12.5	6.8	16.4	11.4	6.2	6.4	20.3	17.9	10.7	24.9	12.9	18.9	6.7	8.8	4.1	5.5	1.1	1.6	1.0	7.4	14.2	5.2	7.0	4.6	9.0	10.4	7.2	10.1	7.7	6.7	6.7	3.9	0.9	4.8	6.6	15.7	5.1	11.0	5.9	6.4	15.7	6.7	8.3	11.2	5.5	4.7	7.4	10.7	3.7	4.9	11.4	6.0	5.6	6.7	8.6	6.9	23.5	7.6	4.9	9.0	4.7	8.4	6.0	13.7	4.5	6.0	11.3	4.0	13.3	2.4	4.7	6.1	11.1	7.2	5.6	6.7	6.7	11.9	8.5	7.7	8.5	7.6	22.5	28.9	3.7	18.5	6.8	9.2	4.1	1.4	1.4	1.6	3.1	1.0	3.9	1.3	1.4	1.4	6.7	1.4	1.4	1.6	1.1	5.5	8.8	1.3	1.0	4.8	5.5	2.5	6.0	5.1	4.1	9.2	2.2	9.4	6.4	35.7	20.6	31.3	5.1	2.6	1.5	14.2	12.7	10.7	13.6	7.0	2.0	5.1	1.7	6.0	1.0	4.3	5.9	0.0	4.6	10.3	4.8	9.5	3.5	16.3	14.1	6.4	6.4	9.8	15.3	0.2	10.9	9.0	5.0	1.0	16.0	7.0	5.6	3.5	3.2	3.0	1.0	6.5	8.0	0.7	4.1	1.9	4.5	7.4	8.8	3.6
LIMS1	"PINCH, PINCH1"	ENSG00000169756	"LIM zinc finger domain containing 1"	P48059	2	108534355-108687246	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 89.8"									"HPA058455, HPA061230"	Approved		Supported	"Focal adhesion sites,Cytosol"		NA	NA		130000000	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723, HPA061230: AB_2684456"	"unprognostic (1.79e-1)"	"unprognostic (8.82e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (7.51e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.11e-1)"	39.3	26.3	7.8	18.3	13.3	14.9	21.5	3.9	9.6	18.1	16.9	14.4	38.2	8.3	21.9	21.7	18.4	16.9	16.5	20.2	8.0	7.5	20.8	18.0	26.3	21.2	13.3	4.6	18.3	10.6	6.6	13.6	19.0	10.8	15.8	9.5	11.0	13.8	43.6	54.0	11.2	17.9	18.8	16.7	24.3	13.0	9.3	10.7	20.2	13.1	15.0	25.5	21.1	16.1	4.4	14.2	45.6	34.0	8.8	20.9	29.6	9.4	10.6	4.2	5.0	7.0	10.2	20.3	10.6	12.2	8.2	8.4	18.4	20.5	9.2	32.5	13.6	12.3	6.1	6.3	10.9	11.1	22.6	11.4	48.1	7.5	9.7	16.0	8.9	89.8	9.8	10.1	21.8	18.0	9.9	29.8	8.1	16.9	12.8	25.3	7.8	8.6	6.6	8.3	6.2	10.9	11.0	14.6	7.4	15.7	17.2	7.6	10.3	16.7	7.1	7.4	5.8	3.7	8.5	40.0	37.5	17.1	8.3	21.7	12.5	16.6	13.1	31.3	10.2	9.5	38.3	16.9	45.6	4.3	28.7	7.8	4.4	18.5	5.7	14.2	3.5	5.0	1.8	8.0	8.8	34.0	1.8	20.9	29.6	7.8	13.3	3.9	9.6	8.0	7.5	13.3	4.6	10.8	10.7	92.3	47.6	42.2	53.7	65.8	24.9	55.7	28.1	57.6	58.0	27.9	51.1	39.0	33.2	68.5	16.9	170.7	21.7	0.0	207.4	109.7	78.3	62.8	99.3	29.3	188.7	14.3	113.4	48.5	145.2	7.9	75.4	215.0	42.2	86.6	18.6	60.5	98.7	14.0	82.7	38.3	18.9	64.7	105.6	36.4	43.6	67.2	23.3	45.9	29.9	55.5
LIMS3		ENSG00000256977	"LIM zinc finger domain containing 3"	P0CW19	2	109898428-109924868	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 11.9;endometrium 1: 9.7"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 1.7;Club cells: 1.2;Distal tubular cells: 1.7;Exocrine glandular cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 9.8;HMC-1: 29.8"									HPA058455	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723"										"unprognostic (2.23e-2)"								1.2	2.8	0.5	2.2	0.5	0.0	1.0	0.8	0.5	1.0	0.7	0.3	4.2	0.2	9.7	2.8	1.2	7.1	0.9	2.6	0.5	0.5	2.6	0.6	0.8	2.8	0.6	0.3	2.2	0.7	0.3	2.4	5.6	0.3	1.0	0.8	0.6	2.2	0.6	3.0	0.8	0.5	1.2	0.6	0.6	0.7	3.7	0.3	0.3	1.0	0.3	0.3	2.6	0.7	0.7	2.5	11.9	5.5	1.1	6.2	8.0	0.0	0.1	1.3	1.5	0.5	0.4	0.0	1.5	0.0	0.2	0.7	1.5	0.0	0.0	4.7	0.3	3.1	0.8	0.0	1.8	1.3	2.4	0.0	9.8	0.5	0.9	1.4	1.7	29.8	2.2	1.1	1.1	1.3	0.0	2.4	0.0	2.0	1.6	3.3	0.1	0.0	0.2	1.6	0.9	0.6	1.8	3.1	1.0	0.8	1.5	0.4	3.6	4.0	0.0	0.8	0.0	0.0	0.5	7.3	6.4	5.9	3.3	0.3	0.0	0.0	1.9	0.8	0.0	1.9	4.7	3.3	11.9	0.9	5.5	1.5	0.7	5.0	1.7	2.5	0.2	0.9	0.3	0.7	1.1	5.2	0.2	6.2	8.0	0.5	0.5	0.8	0.5	0.5	0.5	0.6	0.3	0.3	0.3	0.0	0.3	0.0	0.1	0.1	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
LIMS4	LIMS3L	ENSG00000256671	"LIM zinc finger domain containing 4"	P0CW20	2	110446640-110473075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	26	"Exocrine glandular cells: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.7;HHSteC: 2.5;hTEC/SVTERT24-B: 4.9;HUVEC TERT2: 2.8;U-138 MG: 5.3"									HPA058455	Uncertain		Uncertain	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723"										"unprognostic (2.12e-1)"								4.0	4.1	0.0	0.3	0.0	0.6	1.5	0.0	0.3	0.3	0.6			0.3	4.1	0.3	0.3	3.7	0.3	3.5	0.0	0.0	5.5	2.7	0.8	0.3	0.0		1.9	2.2	0.3	0.8	0.6		0.3	0.3		0.3	0.3	5.6	0.4	0.3	0.3	0.0	0.3	0.3	1.3			1.1		0.3	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	2.7	0.2	0.7	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.2	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LMLN	"Gp63, LMNL1, Msp"	ENSG00000185621	"Leishmanolysin like peptidase"	Q96KR4	3	197960200-198043720	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 32.1;Early spermatids: 29.2;Spermatocytes: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016481, HPA028844"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA016481: AB_1852955, HPA028844: AB_10602347"	"unprognostic (2.54e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.63e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.78e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	3.9	4.9	5.2	2.5	11.0	2.3	4.5	6.1	9.1	6.2	3.5	5.8	14.3	2.2	4.8	20.3	3.5	9.3	5.1	5.9	5.7	7.4	6.6	3.7	8.1	3.5	5.6	8.9	6.5	6.1	8.8	15.0	3.9	11.6	4.6	4.1	5.4	4.2	11.7	3.7	6.5	2.3	4.0	5.5	3.0	3.9	27.0	4.4	1.2	7.6	3.0	2.6	3.5	3.7	1.9	1.9	0.8	2.4	1.8	2.4	1.2	6.5	2.5	2.9	3.5	5.8	8.2	2.5	3.4	3.1	6.1	5.1	2.4	2.4	2.1	15.8	2.4	13.3	2.5	2.7	2.7	9.0	0.3	2.0	1.2	2.1	1.8	3.6	3.6	1.8	3.9	6.1	7.6	5.0	3.6	2.6	5.3	6.3	4.0	5.9	4.8	2.2	3.2	3.3	4.7	5.9	2.5	0.7	2.2	6.3	1.7	4.8	1.4	4.7	4.2	3.4	3.5	11.0	2.8	5.7	7.6	1.1	9.1	5.7	7.1	13.7	0.6	10.8	6.4	6.8	0.2	0.6	0.5	1.2	2.4	1.7	1.9	0.8	1.6	1.9	1.1	2.2	2.4	0.8	1.8	0.9	0.5	0.0	1.2	5.2	11.0	6.1	9.1	5.7	7.4	5.6	8.9	11.6	4.4	14.9	11.3	1.9	1.5	1.8	7.7	9.2	2.5	32.1	13.6	8.7	15.7	2.5	0.0	2.5	29.2	2.5	1.0	0.0	2.3	2.1	3.3	1.9	2.3	2.4	4.2	7.9	4.6	4.3	2.8	18.6	4.4	2.0	3.3	0.0	3.1	7.7	1.8	0.0	5.3	3.7	16.3	0.0	3.2	29.2	24.7	1.5	2.4	1.3	2.3	1.3
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 127.8;urinary bladder: 105.1"	"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 514.4;Late spermatids: 1329.9;Smooth muscle cells: 529.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.5;EFO-21: 36.6;U-698: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Enhanced	"Focal adhesion sites,Cytosol"		NA	NA		520000	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	19.6	4.2	2.7	29.5	2.8	3.1	12.5	3.0	2.7	42.2	29.9	2.1	19.6	5.0	68.6	14.9	59.7	10.0	37.9	9.3	2.6	2.8	10.9	5.3	11.4	6.0	2.8	1.6	26.1	4.4	4.7	3.2	5.2	3.0	37.7	12.8	8.5	7.0	28.4	11.6	5.9	17.2	127.8	3.2	9.5	12.1	30.7	1.5	5.1	5.4	4.2	7.8	105.1	38.3	5.9	4.9	18.0	4.5	4.3	5.0	1.4	7.7	7.1	5.2	3.5	11.3	11.7	5.6	5.1	6.5	3.7	2.5	12.9	3.7	29.5	36.6	11.4	4.6	3.3	1.5	3.4	9.4	3.2	1.7	1.4	5.5	3.4	4.8	0.6	1.7	8.3	4.8	8.3	7.2	5.4	6.2	1.6	0.0	0.6	6.5	2.4	1.5	0.6	2.1	4.9	2.3	1.9	3.9	0.1	4.1	8.2	0.3	0.0	10.9	3.6	6.1	9.0	2.8	2.4	13.4	8.6	6.6	6.1	12.5	0.0	1.1	61.0	4.3	1.3	7.7	0.8	4.5	1.9	5.0	4.2	3.2	2.9	4.3	3.6	2.4	5.9	2.3	2.9	18.0	4.3	4.0	4.9	1.6	1.4	2.7	2.8	3.0	2.7	2.6	2.8	2.8	1.6	3.0	1.5	83.4	55.0	41.3	72.1	69.3	7.7	101.6	99.3	40.2	83.0	66.3	13.7	35.7	24.9	114.3	514.4	83.0	142.7	23.3	78.6	20.6	102.9	124.2	17.4	84.7	36.8	4.8	74.4	114.2	61.5	1329.9	208.5	76.2	75.9	36.1	86.3	27.1	104.6	158.4	448.3	61.0	7.4	329.8	529.6	8.1	6.6	59.6	15.6	39.5	123.5	109.3
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751126-764318	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"gallbladder: 24.6;intestine: 63.8"	"Group enriched"	"Detected in many"	5	"Enterocytes: 892.4;Paneth cells: 434.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 37.2;HaCaT: 27.6;hTCEpi: 25.9;MCF7: 19.0;OE19: 23.2;SK-BR-3: 42.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"		No	No			"Plasma membrane, Focal adhesion sites"		"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	0.5	0.1	0.3	7.9	0.3	0.0	0.7	0.2	0.2	1.5	42.8	0.2	0.2	45.9	0.7	0.8	0.4	2.4	24.6	0.2	0.5	0.2	6.9	0.4	6.8	0.2	0.3	0.3	2.2	2.0	0.0	4.2	2.1	0.2	2.2	13.0	0.2	0.5	0.5	0.2	0.3	63.8	0.7	0.2	0.2	5.8	0.2	0.2	0.3	0.2	0.8	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	37.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.8	13.7	3.2	3.6	0.0	0.0	27.6	0.0	11.6	0.0	0.0	0.0	0.0	14.6	3.9	0.0	0.0	0.5	0.0	25.9	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	19.0	0.0	0.2	0.0	23.2	7.6	0.0	0.1	0.3	9.3	10.3	0.4	0.1	13.2	42.0	0.0	0.0	9.1	0.0	0.0	0.0	4.7	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.5	0.2	0.3	0.3	0.2	0.2	35.7	10.1	2.2	4.0	0.1	0.0	0.4	2.5	26.8	15.9	10.4	0.0	0.3	1.7	48.8	0.4	0.0	892.4	0.0	41.8	2.6	0.3	34.5	9.2	0.0	0.1	0.0	55.7	0.0	0.0	0.7	0.0	0.8	0.0	1.0	139.5	0.0	94.0	434.9	0.0	21.7	0.0	0.0	0.0	0.0	1.5	0.3	1.7	0.0	93.0	40.9
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 34.2;Enterocytes: 39.1;Mucus-secreting cells: 31.9;Paneth cells: 47.6;Urothelial cells: 34.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.2"	"Cell line enriched"	"Detected in some"	7	"HaCaT: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	8.0	1.6	1.8	2.7	3.7	0.5	4.3	0.0	5.1	1.7	7.3	1.6	1.4	3.0	3.2	4.8	4.3	1.5	12.3	0.5	2.8		0.8	0.2	10.3	0.4	0.0	2.9	0.1	1.3	0.5	0.0	0.7	1.3	2.9	4.1	2.7	0.1	2.1	0.6	4.5	9.3	4.3	0.2	0.6	7.2	13.4	0.2	0.0	4.2	4.4	2.5	5.5	2.2	1.1	1.5	0.1	0.2	1.3	7.2	0.9	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.7	0.0	0.1	28.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.0	3.9	0.2	0.6	0.0	0.0	0.0	1.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.0	1.1	0.4	1.7	0.1	0.9	7.2	5.9	0.1	1.3	0.2	1.5	0.0	0.9											26.8	20.8	0.0	5.1	34.2	0.4	1.0	2.5	5.3	5.7	7.0	0.0	0.0	0.0	0.1	5.0	8.1	39.1	0.0	0.3	0.0	1.6	1.8	0.0	0.0	0.1	1.6	3.5	6.2	0.0	7.1	1.1	0.9	3.3	0.0	31.9	9.1	9.7	47.6	2.8	0.7	0.5	6.5	2.0	0.5	2.5	29.0	0.0	0.7	18.5	34.5
MYO5A	"GS1, MYH12, MYO5, MYR12"	ENSG00000197535	"Myosin VA"	Q9Y4I1	15	52307283-52529050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5;parathyroid gland: 47.6"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 82.8;Melanocytes: 92.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;RPMI-8226: 40.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001356	Enhanced		Approved	"Focal adhesion sites,Centriolar satellite"		NA	NA			"Focal adhesion sites, Centriolar satellite"		"HPA001356: AB_1079441"	"unprognostic (1.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.74e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (4.22e-4)"	8.4	7.1	16.6	9.5	27.5	15.7	5.5	27.4	34.5	6.2	4.4	7.8	0.4	3.3	4.2	3.2	5.0	3.6	7.3	4.6	15.9	15.4	4.6	2.7	7.3	11.2	15.6	17.6	5.4	4.3	47.6	10.5	5.2	29.3	4.5	5.2	9.9	4.0	3.4	4.1	10.4	3.9	7.7	10.1	7.3	4.1	4.6	7.1	3.1	6.8	2.7	10.3	7.3	4.2	2.3	5.2	6.3	4.4	0.7	4.5	1.9	5.5	9.8	5.2	6.3	5.3	6.5	5.6	10.1	9.1	5.4	4.2	0.9	2.2	5.3	2.6	12.0	7.9	4.6	12.0	10.4	6.7	30.0	2.8	4.9	2.5	1.2	2.7	2.6	4.8	4.3	6.5	7.9	15.8	5.3	31.4	3.5	0.1	60.0	10.4	9.8	2.3	0.3	2.4	0.1	7.8	4.2	8.4	40.7	4.4	4.0	3.8	2.3	9.4	7.8	18.3	4.0	4.1	2.9	15.0	10.9	4.7	5.1	9.8	6.2	13.8	6.4	11.9	7.5	15.7	0.9	4.4	5.4	2.9	3.6	4.5	2.3	2.9	1.9	5.2	1.6	0.5	1.0	6.3	0.7	2.6	3.1	4.1	1.9	16.6	27.5	27.4	34.5	15.9	15.4	15.6	17.6	29.3	7.1	11.9	10.7	12.3	8.4	18.4	82.8	8.7	5.1	9.4	29.6	14.0	37.3	0.5	0.0	4.8	16.0	9.0	0.0	0.0	5.4	0.4	6.0	6.8	22.0	1.0	21.3	25.4	1.2	1.8	24.4	6.4	3.4	39.4	92.8	27.9	0.0	4.5	5.0	0.8	1.8	2.2	27.1	6.5	4.7	8.7	7.0	10.2	0.9	12.9	0.0	7.4
NOB1	"ART-4, MST158, NOB1P, PSMD8BP1"	ENSG00000141101	"NIN1/PSMD8 binding protein 1 homolog"	Q9ULX3	16	69741867-69754940	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041522, HPA049430, HPA067411"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"HPA041522: , HPA049430: AB_2680764, HPA067411: "	"unprognostic (5.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.61e-3)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.21e-5)"	"prognostic unfavorable (8.16e-4)"	"unprognostic (3.26e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.16e-1)"	18.2	31.6	9.9	14.5	18.0	17.4	18.9	13.4	16.2	18.8	19.4	12.5	12.4	20.3	21.3	15.5	25.4	29.2	19.0	13.3	9.6	9.7	18.4	23.4	13.3	21.3	12.9	7.5	37.5	68.5	13.9	10.1	13.1	13.5	21.5	12.7	13.0	20.4	14.8	26.3	25.1	15.5	18.0	10.1	21.5	20.5	11.6	15.4	23.7	28.9	25.8	29.0	25.6	18.4	21.0	20.3	2.0	15.0	24.5	26.1	17.3	14.8	32.6	7.7	21.8	17.1	27.1	15.3	11.9	16.7	22.4	20.4	36.9	24.5	33.2	18.7	13.2	11.8	22.1	21.1	26.7	13.3	8.3	24.6	12.9	15.4	47.3	30.4	23.8	10.9	34.2	22.8	25.8	33.0	20.9	18.9	20.2	29.4	10.3	11.1	38.9	29.9	47.7	23.6	16.6	19.4	33.2	7.9	41.9	16.6	14.5	20.0	9.9	37.6	13.2	18.6	7.1	14.3	21.6	14.3	15.3	13.9	13.9	19.4	17.0	12.9	58.5	15.3	21.8	16.8	0.1	15.0	2.0	17.6	12.7	24.6	19.4	21.4	16.1	20.3	21.0	23.1	21.0	0.7	24.5	9.5	10.5	26.1	17.3	9.9	18.0	13.4	16.2	9.6	9.7	12.9	7.5	13.5	15.4	3.0	13.1	37.1	60.4	53.2	9.7	4.8	15.3	18.7	46.6	19.2	0.0	58.6	34.9	34.6	8.8	42.1	15.8	23.3	74.6	74.1	39.0	28.3	16.1	13.2	32.4	4.8	9.8	18.4	20.2	5.9	33.9	23.1	20.3	37.9	33.2	10.5	44.9	17.5	40.0	27.6	4.6	25.8	39.2	17.4	28.1	52.1	39.7	37.4	50.6	54.8
PDLIM2		ENSG00000120913	"PDZ and LIM domain 2"	Q96JY6	8	22578279-22598025	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 81.6"	"Cell type enhanced"	"Detected in many"	12	"Syncytiotrophoblasts: 663.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003880	Approved		Supported	"Actin filaments,Focal adhesion sites"		NA	NA			"Actin filaments, Focal adhesion sites"		"HPA003880: AB_1855149"	"unprognostic (1.04e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-3)"	"unprognostic (9.33e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.37e-7)"	"unprognostic (6.14e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.08e-3)"	10.4	7.0	5.4	10.9	5.9	6.0	10.4	16.2	7.9	19.8	27.6	8.4	7.7	17.8	11.1	11.0	41.1	9.0	19.9	10.1	6.3	5.0	20.9	16.4	26.5	17.2	6.9	7.1	13.1	15.6	2.2	5.7	42.3	10.8	11.2	3.2	11.3	12.4	10.0	53.5	48.8	32.2	16.2	10.1	81.6	5.6	8.5	5.0	7.5	5.5	23.4	21.0	12.7	23.2	9.6	12.4	49.3	20.2	8.7	16.4	10.2	22.9	14.2	9.6	16.9	19.0	32.6	10.9	36.4	27.3	26.2	26.6	16.2	3.8	9.5	10.3	32.8	4.8	11.7	5.4	24.8	5.1	0.0	3.7	2.9	9.3	11.7	24.1	3.3	23.1	34.7	3.1	12.8	3.5	20.7	14.3	5.3	0.8	6.2	17.7	12.1	4.2	3.9	7.9	9.7	1.4	3.4	1.8	1.0	4.6	4.7	3.0	7.2	7.6	20.8	32.9	6.0	7.3	6.7	17.7	28.5	29.4	34.1	16.6	0.1	0.2	3.0	29.4	13.2	20.9	22.7	15.5	49.3	16.4	20.2	14.6	8.4	12.4	16.1	12.4	9.6	8.6	12.2	32.9	8.7	19.4	8.0	12.8	10.2	5.4	5.9	16.2	7.9	6.3	5.0	6.9	7.1	10.8	5.0	71.5	9.6	36.7	11.1	84.4	2.3	7.6	22.9	0.0	18.2	17.4	0.0	44.5	13.3	24.7	0.8	39.4	132.3	23.3	23.2	92.2	139.6	25.2	27.6	40.4	50.0	3.2	1.2	92.7	45.1	1.5	122.3	51.2	45.5	1.8	8.4	19.8	61.5	119.3	205.1	104.7	3.1	58.2	92.0	0.7	4.5	88.1	663.2	89.7	11.3	15.2
PDLIM7	ENIGMA	ENSG00000196923	"PDZ and LIM domain 7"	Q9NR12	5	177483394-177497606	"Predicted intracellular proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 159.6"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 173.8;Exocrine glandular cells: 213.2;Pancreatic endocrine cells: 210.7;Peritubular cells: 209.7;Sertoli cells: 161.7;Smooth muscle cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 27.2;eosinophil: 20.5;neutrophil: 80.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 80.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018794, HPA048815"	Approved		Enhanced	"Actin filaments,Focal adhesion sites"		NA	NA		7600000	"Actin filaments, Focal adhesion sites"		"HPA018794: AB_1855155, HPA048815: AB_2680530"	"unprognostic (7.70e-3)"	"unprognostic (3.75e-2)"	"unprognostic (9.27e-3)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.18e-3)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.19e-10)"	"unprognostic (6.72e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.68e-2)"	12.4	5.6	3.7	21.1	9.3	12.5	8.3	0.5	5.9	54.6	76.0	3.2	42.6	9.0	85.0	35.8	33.9	35.5	52.3	11.1	3.8	5.0	8.3	2.4	11.6	8.9	3.5	5.8	28.2	3.1	2.1	10.3	11.5	5.6	42.0	7.6	17.6	9.1	61.7	159.6	5.3	16.5	129.5	3.1	12.7	27.0	11.7	2.4	3.7	5.4	24.9	6.5	67.8	19.6	1.8	4.8	80.6	8.4	0.4	1.4	3.9	24.9	5.0	23.9	18.8	6.5	11.9	24.2	47.9	26.1	27.3	19.6	9.6	22.6	4.5	49.5	29.3	15.0	12.1	3.9	32.4	6.3	6.2	5.8	14.7	16.3	9.0	17.7	7.8	49.6	25.8	5.5	21.8	10.5	38.7	16.3	4.1	10.9	3.2	19.7	19.3	1.4	17.3	16.5	4.8	21.5	29.1	21.3	2.8	18.2	5.1	3.7	7.8	18.7	3.6	9.1	8.4	5.1	7.0	58.6	32.9	35.7	12.5	43.7	0.8	0.9	5.3	15.6	8.4	7.4	27.2	8.4	20.5	0.9	3.9	1.1	1.8	0.6	1.4	4.8	1.0	0.6	0.7	80.6	0.4	4.9	0.3	1.2	3.9	3.7	9.3	0.5	5.9	3.8	5.0	3.5	5.8	5.6	2.4	0.0	1.1	5.9	34.1	12.9	5.2	16.1	5.1	4.0	2.3	24.4	13.7	10.1	21.6	173.8	19.2	30.0	1.3	0.0	213.2	44.5	47.3	13.0	17.3	0.9	64.5	7.9	3.4	50.3	15.5	30.6	41.4	23.5	10.1	34.3	1.9	12.4	210.7	35.1	209.7	6.7	20.4	161.7	171.6	10.9	35.2	13.8	11.8	14.9	1.7	21.1
PPFIA1	"LIP.1, LIPRIN"	ENSG00000131626	"PTPRF interacting protein alpha 1"	Q13136	11	70270700-70385312	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 80.2;SK-MEL-30: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017032, HPA042271"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"CAB017032: , HPA042271: AB_2677923"	"unprognostic (1.89e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (7.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.14e-2)"	28.9	18.6	20.9	17.5	20.8	20.8	40.5	22.8	24.1	15.9	18.3	27.7	18.5	15.5	26.2	20.4	19.4	16.9	23.9	19.3	19.7	12.0	18.1	15.5	25.4	15.9	18.9	17.8	21.0	17.7	21.2	34.1	24.9	20.7	13.8	16.3	21.9	19.0	18.5	38.7	24.2	17.8	18.4	30.0	14.7	15.6	29.8	22.5	17.0	25.2	10.0	13.6	18.7	18.6	2.6	2.8	10.0	4.8	1.1	2.2	1.0	80.2	10.8	10.0	6.7	9.3	5.8	10.6	9.4	7.7	11.7	7.8	20.5	7.2	7.5	12.3	7.5	12.0	11.6	8.4	8.1	10.1	5.0	5.9	6.0	11.3	6.5	9.5	7.9	7.4	7.4	13.0	15.1	12.4	9.4	7.5	6.4	10.1	6.1	10.2	10.9	5.4	4.7	5.9	17.1	9.3	6.3	25.1	6.5	5.7	11.0	9.7	6.6	14.0	17.7	46.1	10.8	11.9	8.4	10.3	11.8	9.2	16.3	10.0	7.5	4.7	10.5	9.8	5.5	13.7	0.0	3.6	1.7	1.3	1.9	2.2	2.6	2.2	1.9	2.8	2.3	1.7	1.0	10.0	1.1	4.8	2.8	2.1	1.0	20.9	20.8	22.8	21.4	19.7	12.0	18.9	17.8	20.7	22.5	23.8	49.3	8.8	18.7	24.4	31.5	23.0	22.9	26.8	25.0	17.4	29.5	30.5	10.0	19.2	163.8	25.1	26.3	0.0	17.6	12.0	18.6	32.7	8.1	19.8	21.9	31.8	25.8	20.3	35.7	71.1	25.6	27.2	20.3	20.8	17.6	75.0	27.2	20.3	24.1	18.0	43.9	19.4	21.9	47.9	72.2	29.0	62.1	17.3	16.9	36.9
PRAG1	"DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223"	ENSG00000275342	"PEAK1 related, kinase-activating pseudokinase 1"	Q86YV5	8	8317736-8386498	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 6.2;Cytotrophoblasts: 6.4;Ductal cells: 6.6;Extravillous trophoblasts: 5.5;Hofbauer cells: 14.8;Pancreatic endocrine cells: 5.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 27.5;NTERA-2: 17.8;SuSa: 19.0"	"Low region specificity"	"Detected in all"							"HPA011776, HPA012066"	Uncertain		Uncertain	"Nucleoli,Focal adhesion sites"		NA	NA			Nucleoli	"Focal adhesion sites"	"HPA011776: , HPA012066: AB_1847706"	"unprognostic (7.04e-3)"	"unprognostic (7.90e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.19e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.22e-3)"	7.6	0.2	6.4	8.8	4.9	0.1	5.4	30.4	7.0	2.4	5.7	1.8	3.2	9.8	0.8	1.7	2.6	5.0	4.0	1.8	2.1		1.3	0.9	4.3	9.1	0.0	1.4	1.7	1.0	2.2	0.0	5.4	1.2	1.5	3.4	0.0	1.7	5.7	5.6	2.8	9.4	0.9	1.4	5.7	3.9	0.7	1.2	1.8	15.4	4.7	6.2	1.5	0.2	3.1	4.6	2.2	1.6	1.3	3.9	0.4	3.3	27.5	3.1	0.4	0.0	0.2	7.8	7.0	1.5	2.8	1.1	13.6	8.0	5.5	4.8	3.3	7.6	12.0	0.5	8.4	0.6	0.2	0.8	0.0	3.3	7.6	3.0	0.8	8.7	0.7	5.5	0.4	1.2	1.6	5.7	0.8	0.0	0.0	2.1	4.6	0.7	2.6	17.8	10.5	7.1	3.5	3.3	1.3	4.1	9.5	1.5	1.0	2.7	7.7	2.7	19.0	6.0	3.4	7.5	0.2	7.4	0.0	1.7	0.4	0.6	7.5	1.7	1.8	4.1	0.0	0.5	2.2	1.2	0.1	0.9	3.1	1.5	0.4	0.7	2.6	3.9	3.2	0.0	1.3	1.6	4.6	0.2	0.4											8.9	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	6.4	0.0	6.6	0.0	0.0	0.0	0.0	2.7	5.5	0.0	0.0	2.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.8	0.0	0.0	5.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
PWWP2A	KIAA1935	ENSG00000170234	"PWWP domain containing 2A"	Q96N64	5	160061801-160119423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Cell type enhanced"	"Detected in all"	5	"Bipolar cells: 94.1;Horizontal cells: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046733, HPA058233"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA046733: AB_2679777, HPA058233: AB_2683647"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.24e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.51e-4)"	8.4	9.3	9.5	12.7	22.3	11.9	9.1	52.7	16.0	14.4	13.6	19.9	5.3	9.6	10.8	7.2	8.7	9.5	8.1	7.4	15.9	8.8	10.3	8.6	9.8	12.0	25.2	8.9	10.5	10.5	10.6	15.1	11.2	17.0	11.9	14.7	10.3	8.8	8.4	7.0	14.7	10.6	9.3	13.8	12.5	11.8	6.3	21.3	18.6	9.8	5.8	11.4	10.7	10.1	6.0	2.9	6.0	4.4	1.1	4.9	0.9	10.7	5.2	13.5	11.5	15.1	11.8	19.1	8.6	7.0	7.7	7.9	16.8	21.0	17.4	13.2	6.6	12.6	7.8	11.7	13.5	12.7	18.0	13.0	12.5	9.6	8.6	11.5	12.5	9.5	8.4	6.7	15.5	11.8	17.3	12.3	9.9	9.5	11.3	13.0	9.0	10.7	12.2	15.9	9.2	6.7	16.9	12.0	11.1	9.4	7.7	15.9	11.1	14.5	14.7	15.6	11.5	11.3	13.9	16.4	13.5	9.3	10.0	16.7	13.0	11.6	15.5	8.8	12.7	13.2	6.0	4.4	2.4	2.8	2.0	2.2	6.0	3.0	3.3	2.9	3.7	4.9	2.7	5.0	1.1	2.6	2.7	2.5	0.9	9.5	22.3	52.7	16.0	15.9	8.8	25.2	8.9	17.0	21.3	8.9	14.8	18.5	12.5	28.3	94.1	10.6	10.2	14.7	17.0	19.2	68.7	11.2	14.9	11.6	1.5	15.3	18.4	23.3	9.6	10.5	16.2	15.6	23.1	7.6	7.8	89.0	31.6	12.9	11.0	2.1	51.8	14.6	10.1	12.6	19.4	22.7	13.1	14.4	36.0	5.8	50.6	25.8	22.6	9.7	17.2	22.6	7.8	17.3	20.4	11.2
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8"	"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 1.9;Early spermatids: 5.0;Late spermatids: 4.2;Suprabasal keratinocytes: 5.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.9;HeLa: 21.8;hTCEpi: 15.8;SiHa: 7.5;U-87 MG: 6.8"									HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA			"Focal adhesion sites"	Cytosol	"HPA054022: AB_2797250"	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	1.6	0.5	0.2	0.5	0.2	0.0	1.4	0.2	0.2	10.4	0.3	0.2	0.2	0.2	0.8	0.6	39.7	0.6	0.2	0.2	0.2	0.0	2.8	0.2	0.6	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.5	0.2	0.4	0.3	0.2	7.0	0.2	0.7	14.6	0.3	0.3	0.2	0.6	0.2	0.5	0.3	0.3	0.2	19.8	22.5	1.3	12.6	0.6	0.4	2.3	0.6	0.5	0.7	0.1	1.5	0.9	0.0	0.0	0.2	1.3	0.1	0.1	0.9	0.1	0.3	0.0	3.7	0.0	2.1	3.1	2.0	1.7	0.0	15.9	0.2	0.4	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.3	15.8	0.9	3.3	0.5	0.1	0.0	0.0	1.3	0.9	0.1	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.2	0.3	0.7	0.2	0.0	7.5	2.0	0.0	0.0	1.1	0.0	3.0	1.1	0.4	0.1	0.9	0.0	0.0	0.0	6.8	0.3	0.0	2.0	0.6	0.4	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.6	0.7	0.4	2.3	0.5	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.9	1.9	0.6	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.8
RALA	RAL	ENSG00000006451	"RAS like proto-oncogene A"	P11233	7	39623483-39708124	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Exocytosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Pancreatic endocrine cells: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047037, HPA065232"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA047037: , HPA065232: AB_2685440"	"unprognostic (1.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (7.71e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (7.46e-4)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.95e-2)"	19.2	25.2	24.7	14.3	24.6	4.8	24.4	16.1	22.0	18.4	22.3	17.2	8.0	23.5	15.7	15.5	44.9	15.0	20.0	13.8	24.7	20.2	15.9	15.4	30.3	14.8	27.6	18.9	17.4	11.6	12.8	14.2	23.7	20.3	12.9	23.6	9.1	18.5	12.7	16.8	19.5	25.5	15.7	36.0	16.0	24.4	12.2	21.9	19.9	13.8	31.0	28.9	15.2	20.8	13.3	16.3	21.5	11.2	15.7	20.4	11.5	20.1	4.6	11.4	9.9	21.8	18.2	7.9	17.7	25.6	16.1	17.9	11.5	9.9	10.4	6.7	13.7	15.1	21.0	16.1	11.5	27.9	9.9	7.6	8.1	7.6	8.4	35.4	14.0	11.5	14.3	14.1	28.7	40.9	20.2	78.1	10.2	16.2	6.9	16.3	6.5	9.8	16.7	32.1	22.1	9.2	12.3	10.3	9.0	16.4	9.4	20.5	19.9	10.9	17.5	12.0	21.5	16.4	15.4	25.0	9.5	8.5	12.0	12.6	12.3	9.5	12.7	10.7	14.6	17.3	21.5	9.8	11.0	9.7	11.2	12.0	11.5	15.7	12.4	16.3	13.3	20.4	17.9	4.5	15.7	8.6	10.6	19.7	11.5	24.7	24.6	16.1	20.8	24.7	20.2	27.6	18.9	20.3	21.9	77.4	36.8	45.3	32.8	80.0	10.9	33.0	45.9	29.4	21.6	22.7	5.9	45.4	18.3	162.0	51.6	66.4	59.6	23.3	107.3	77.4	54.6	33.5	31.1	26.2	97.6	11.1	45.8	69.3	24.5	12.3	44.3	67.7	28.7	146.1	46.5	37.7	277.8	66.0	65.4	28.4	15.8	32.3	24.7	52.6	55.6	95.7	51.8	25.5	51.1	47.7
RASAL2	nGAP	ENSG00000075391	"RAS protein activator like 2"	Q9UJF2	1	178094141-178484147	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 143.3;Rod photoreceptor cells: 179.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018805, HPA020453"	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA018805: AB_1856085, HPA020453: AB_1856086"	"unprognostic (5.55e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (2.05e-4)"	13.5	3.8	4.2	2.8	5.1	0.4	7.1	2.7	8.5	9.5	4.2	3.7	4.2	2.4	10.9	5.5	24.4	5.8	9.0	15.5	3.8	5.9	7.1	2.7	9.2	1.5	4.0	6.5	6.3	5.0	6.1	6.7	21.2	5.6	5.0	4.3	10.7	9.6	4.5	8.3	7.5	3.3	7.1	3.8	2.9	3.7	9.0	2.7	0.0	5.0	13.1	4.8	5.6	13.2	2.1	0.5	1.4	0.6	0.3	0.1	0.0	16.3	5.4	7.1	2.3	4.8	6.5	9.9	8.2	8.0	7.0	5.3	8.6	8.7	0.0	13.7	8.0	11.5	13.8	5.7	13.1	6.5	0.0	3.1	0.0	5.7	3.4	5.7	2.3	0.3	20.4	2.6	8.3	30.0	7.3	6.3	0.0	0.5	0.0	9.7	1.7	0.0	1.9	5.3	3.1	1.0	0.1	2.9	0.0	3.8	2.2	5.5	2.7	6.4	5.0	5.0	6.3	5.8	2.6	11.9	9.3	9.5	9.7	10.9	3.6	0.0	0.0	7.3	1.2	6.6	1.4	0.4	0.1	0.1	0.3	0.0	0.6	0.0	0.0	0.2	2.1	0.1	0.1	0.8	0.3	0.6	0.5	0.0	0.0	4.2	5.1	2.7	7.1	3.8	5.9	4.0	6.5	5.6	2.7	71.5	11.7	1.4	7.8	14.2	47.0	33.2	17.8	37.5	14.8	15.7	143.3	11.6	5.0	19.0	12.3	41.2	5.2	0.0	10.9	12.1	14.7	18.7	7.0	5.4	15.0	79.4	32.7	43.0	2.5	5.1	18.1	13.1	3.3	12.6	14.6	22.8	23.0	2.9	21.5	5.7	179.6	64.7	27.8	28.6	32.2	21.1	35.0	0.7	12.8	29.3
SENP1		ENSG00000079387	"SUMO1/sentrin specific peptidase 1"	Q9P0U3	12	48042898-48106308	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011765, HPA046491"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA011765: AB_1079907, HPA046491: AB_2679672"	"unprognostic (2.66e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.20e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-1)"	5.7	3.3	3.0	9.0	4.0	8.4	5.2	5.3	3.2	5.5	4.9	3.8	3.5	3.4	6.2	4.3	5.7	5.2	3.8	3.6	2.7	3.3	3.8	3.9	4.3	7.3	3.0	2.3	6.2	4.4	6.1	11.4	8.1	3.0	4.4	4.7	5.1	20.0	4.7	6.8	6.6	4.5	5.8	4.3	6.4	4.5	60.2	3.6	15.0	5.2	4.8	8.3	5.7	6.3	5.3	3.8	7.1	2.6	3.8	5.5	2.3	7.1	9.2	11.5	8.6	3.4	5.1	8.5	7.7	8.6	13.2	10.8	11.3	11.6	19.4	6.7	7.0	5.2	7.0	14.2	6.8	13.5	17.6	6.4	17.0	8.9	5.4	5.7	15.8	11.5	4.1	5.6	11.9	10.6	5.9	6.9	13.2	14.9	9.3	6.8	5.7	19.7	5.0	10.5	4.9	7.0	18.7	12.1	9.5	3.6	8.8	12.1	8.3	11.1	6.8	4.5	6.8	10.7	7.6	6.3	11.2	10.1	6.5	8.1	9.6	15.5	19.0	6.9	36.8	5.1	2.0	1.8	7.1	4.3	2.6	5.5	2.4	4.2	3.9	3.3	5.3	3.6	4.1	3.8	3.8	2.0	3.8	5.0	2.3	3.0	4.0	5.3	3.2	2.7	3.3	3.0	2.3	3.0	3.6	8.9	6.2	5.6	4.2	3.3	8.2	2.1	7.6	5.3	10.3	3.5	3.9	3.1	3.3	3.0	10.2	6.3	2.5	0.0	5.6	2.8	3.7	3.6	5.8	6.6	3.8	14.3	3.4	7.4	10.0	3.3	5.8	4.8	1.7	5.4	3.7	4.8	4.5	2.0	6.3	3.4	8.3	0.0	3.1	64.4	24.9	5.4	2.3	4.4	3.6	3.0
SIKE1	"FLJ21168, SIKE"	ENSG00000052723	"Suppressor of IKBKE 1"	Q9BRV8	1	114769479-114780685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024177, HPA025726"	Supported		Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Vesicles	"HPA024177: AB_1848798, HPA025726: AB_1848800"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.52e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.05e-1)"	18.3	15.4	14.5	17.4	15.9	15.3	16.4	23.5	16.3	18.3	17.3	14.5	14.2	16.7	17.2	13.4	18.1	14.3	13.4	20.3	14.2	15.1	24.4	22.2	12.3	19.7	21.1	11.2	17.2	17.5	15.4	22.5	17.1	23.2	15.2	17.3	9.3	17.2	13.9	21.1	21.9	17.5	16.4	19.2	20.6	14.5	11.8	17.9	26.0	19.3	17.1	21.2	17.2	14.2	8.1	9.8	12.3	7.6	9.2	10.3	5.3	8.5	2.4	11.4	10.8	13.7	10.9	12.2	7.1	6.7	10.4	14.1	7.5	4.5	16.0	7.0	6.0	4.5	8.3	12.5	8.5	14.1	10.8	7.3	8.8	7.6	7.7	13.0	10.0	7.2	10.7	9.8	7.5	12.1	6.5	9.3	12.6	13.4	10.3	7.9	38.1	17.5	9.0	25.7	4.8	7.4	10.5	23.4	8.1	7.6	7.8	8.7	9.7	11.2	11.0	12.8	10.6	6.6	33.5	6.5	8.7	11.5	14.5	9.9	8.7	7.5	15.7	12.4	15.2	18.7	12.3	6.0	7.4	8.6	6.4	10.3	7.9	8.0	7.4	7.8	8.1	9.3	9.9	4.0	9.2	7.6	9.8	6.2	5.3	14.5	15.9	23.5	16.3	14.2	15.1	21.1	11.2	23.2	17.9	23.8	11.3	20.5	20.8	28.3	9.9	37.2	20.4	8.1	13.6	29.6	9.8	26.2	43.1	24.9	28.0	21.2	22.5	0.0	22.3	29.0	22.4	24.9	19.6	33.5	24.5	7.9	17.9	24.5	15.8	47.2	26.2	19.8	21.9	18.0	20.8	14.1	27.5	20.1	18.7	46.0	14.7	19.4	21.7	28.6	31.3	31.9	30.1	30.9	19.8	19.5
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 70.9"	"Cell type enhanced"	"Detected in some"	9	"Leydig cells: 4.0;Melanocytes: 5.0;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;RT4: 4.5;SiHa: 6.5;T-47d: 7.8;U-266/70: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075017	Enhanced		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA			"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	1.6	2.6	1.9	0.8	5.1	1.2	0.8	0.8	3.3	0.8	0.8	0.8	0.8	0.5	1.3	0.8	1.1	1.2	2.7	2.9	2.7	2.9	0.8	0.8	0.8	0.9	2.8	0.8	0.8	2.1	0.0	2.6	0.8	1.3	4.0	0.0	70.9	10.0	0.8	1.9	4.2	0.8	0.8	3.7	1.8	2.3	2.0	0.8	0.8	0.9	0.8	0.8	1.6	0.8	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.4	0.7	1.2	0.2	0.0	0.0	6.1	0.5	0.0	0.0	0.0	1.3	3.5	0.4	1.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.9	0.3	1.0	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	1.6	0.0	4.0	0.0	0.0	1.4	0.1	0.1	2.0	0.0	0.0	0.0	4.5	2.0	0.3	6.5	0.3	1.0	0.6	7.8	0.2	0.0	0.0	3.6	0.3	0.0	11.5	1.6	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	5.1	0.8	1.2	2.7	2.9	2.8	0.8	1.3	0.8	0.0	0.0	0.0	0.5	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	0.0	0.0	1.3	0.3	1.6	4.0	0.0	5.0	0.0	0.0	0.9	0.2	0.0	2.1	0.0	0.5	0.0	0.9	0.9	4.1	0.6	0.0	0.0	0.0	0.1
SNX32	"FLJ30934, SNX6B"	ENSG00000172803	"Sorting nexin 32"	Q86XE0	11	65833641-65856896	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 16.6"	"Cell type enhanced"	"Detected in some"	12	"Early spermatids: 10.4;Late spermatids: 8.2;Spermatocytes: 4.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.1;HSkMC: 8.0;REH: 2.6;SH-SY5Y: 3.1;U-266/70: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041775	Uncertain		Uncertain	"Cell Junctions,Focal adhesion sites"		NA	NA			"Cell Junctions, Focal adhesion sites"		"HPA041775: AB_10797268"	"unprognostic (6.74e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.00e-1)"	"unprognostic (9.28e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.36e-2)"	0.8	1.0	9.0	1.1	16.6	1.3	1.3	3.5	16.1	1.6	2.2	1.6	0.0	3.4	2.0	1.3	0.9	2.5	2.8	0.9	10.2	5.0	0.9	0.7	0.8	1.0	3.6	10.9	1.3	0.8	0.8	0.3	0.9	3.4	0.8	1.9	0.1	0.7	0.9	0.6	1.1	1.5	2.0	1.8	0.9	0.9	3.5	3.7	0.0	0.7	0.0	1.3	1.0	0.2	1.0	1.2	0.2	0.3	0.1	3.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	0.7	8.0	0.1	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.4	0.0	0.5	0.3	0.1	0.0	0.0	2.6	0.0	2.3	0.1	0.0	0.0	3.1	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	9.3	1.6	0.0	0.7	0.0	0.3	0.0	0.1	0.0	1.2	0.3	3.0	0.3	1.6	1.2	1.2	1.0	1.4	0.6	0.2	0.1	0.0	0.7	1.2	0.4	9.0	16.6	3.5	15.4	10.2	5.0	3.6	10.9	3.4	3.7	0.0	1.1	0.0	0.3	0.3	1.7	0.8	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	10.4	0.5	0.8	0.0	0.0	0.1	0.6	0.1	3.5	0.0	0.3	0.0	0.0	0.6	0.0	8.2	0.3	0.0	1.7	0.0	0.3	0.8	0.1	0.0	1.1	0.2	0.5	0.0	0.3	4.4	1.3	0.4	0.0	0.0	1.2	0.1
SORBS3	"SCAM-1, SH3D4, vinexin"	ENSG00000120896	"Sorbin and SH3 domain containing 3"	O60504	8	22544986-22575788	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 147.7;Late spermatids: 378.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015849	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA		6600	Cytosol	"Focal adhesion sites"	"HPA015849: AB_1857365"	"unprognostic (6.15e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.88e-4)"	"unprognostic (4.21e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.53e-5)"	52.2	22.6	25.0	16.8	23.2	3.3	56.5	31.4	27.0	49.3	28.9	21.9	19.2	19.6	40.6	32.0	27.5	33.8	42.8	32.8	27.3	12.8	28.1	41.8	38.9	28.7	21.3	18.0	49.0	21.7	27.0	24.1	43.3	22.8	38.0	23.7	45.8	36.6	34.5	29.5	32.0	34.5	41.9	24.1	28.6	20.4	36.0	21.2	3.4	29.7	36.2	15.7	38.4	44.7	0.8	5.6	0.4	3.2	4.0	17.4	3.3	22.6	28.6	15.6	17.6	25.4	33.9	16.0	23.3	36.2	27.3	17.0	28.9	10.2	0.2	15.9	36.3	11.0	19.5	23.4	21.3	14.2	15.9	10.2	1.9	16.1	13.2	28.9	0.2	0.1	21.3	15.9	9.5	14.0	30.5	21.1	12.1	4.9	0.7	19.4	8.9	1.9	0.7	5.5	3.9	12.0	21.7	10.6	2.1	12.4	4.4	0.9	14.1	11.4	2.8	14.4	17.1	4.7	8.1	32.8	24.3	17.4	17.7	16.4	0.4	0.6	3.0	14.2	5.4	16.4	0.0	1.6	0.4	8.6	3.2	17.4	0.6	9.4	9.9	5.6	0.8	9.7	5.6	0.4	4.0	0.7	1.9	0.4	3.3	25.0	23.2	31.4	27.0	27.3	12.8	21.3	18.0	22.8	21.2	17.9	4.5	3.0	20.1	26.0	2.0	8.0	25.5	9.4	11.4	12.2	0.0	21.8	8.3	18.5	147.7	38.9	46.6	0.0	16.9	25.1	46.3	33.6	17.3	37.5	30.7	4.8	14.0	75.5	27.9	378.2	56.7	18.7	23.6	1.8	35.7	20.2	20.5	48.2	55.2	20.3	3.1	58.2	68.3	5.5	6.1	18.6	17.2	14.1	25.3	21.6
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Leydig cells: 85.4;Peritubular cells: 168.3;Sertoli cells: 219.9;Smooth muscle cells: 134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		13000000	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	16.8	4.1	1.0	14.4	1.4	0.3	18.5	1.2	1.6	42.9	51.1	1.8	22.1	5.8	80.7	22.7	34.1	28.9	36.2	11.8	0.9	0.7	8.6	2.8	11.2	10.6	1.1	1.3	40.3	2.2	5.1	1.8	11.5	2.3	37.7	10.4	11.1	7.1	34.7	5.7	5.9	12.8	71.9	1.8	11.5	19.6	10.9	0.9	0.7	5.8	7.8	3.6	69.9	23.5	1.3	0.5	8.8	0.0	0.0	2.5	2.3	4.2	5.3	8.7	0.0	8.6	15.8	0.1	22.8	21.4	14.3	9.7	2.2	1.4	0.0	21.5	19.5	9.6	6.3	1.8	4.2	18.8	0.0	0.0	5.0	9.8	1.1	22.0	0.0	6.5	10.2	6.2	8.9	5.3	33.8	9.4	0.0	0.5	0.0	17.4	0.0	0.0	0.5	0.4	0.4	5.4	0.0	10.4	0.0	4.0	2.1	0.0	6.2	8.8	0.0	4.4	7.4	0.0	0.5	25.4	25.8	6.3	7.1	9.9	0.0	0.0	0.0	11.4	0.2	15.8	8.8	0.0	0.1	0.3	0.0	0.5	1.3	1.4	0.2	0.1	0.5	0.2	1.0	0.2	0.0	0.0	0.5	2.5	2.3	1.0	1.4	1.2	1.6	0.9	0.7	1.1	1.3	2.3	0.9	6.0	3.7	0.0	18.4	11.2	0.4	8.1	2.5	0.0	2.3	7.0	0.0	1.2	6.6	27.3	0.9	35.1	1.6	0.0	20.6	1.5	58.4	4.7	5.8	0.0	11.3	0.0	0.0	30.7	0.8	2.1	85.4	3.2	38.8	7.2	4.2	7.1	19.0	0.0	168.3	12.6	1.3	219.9	134.8	1.1	2.7	9.8	1.5	0.5	5.3	4.4
TLE2	"ESG, ESG2, FLJ41188, GRG2"	ENSG00000065717	"Transducin like enhancer of split 2"	Q04725	19	2997638-3047635	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 37.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 85.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 3.1;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.1;RT4: 20.0;T-47d: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049103	Enhanced		Supported	"Nuclear bodies,Focal adhesion sites"		NA	NA			"Nuclear bodies"	"Focal adhesion sites"	"HPA049103: AB_2680631"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.87e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.39e-6)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.49e-6)"	"unprognostic (2.66e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.88e-4)"	13.4	9.6	9.2	4.6	5.7	1.3	38.3	85.3	16.5	10.9	11.4	4.9	28.6	8.1	15.7	6.6	5.5	13.3	8.5	19.9	5.5	7.6	11.9	3.5	12.5	5.4	8.3	5.3	12.4	16.5	13.8	6.4	7.3	9.7	12.9	4.6	20.6	55.5	27.1	38.5	6.4	5.3	26.2	13.3	10.9	7.4	6.3	4.8	1.1	17.5	5.7	3.2	19.2	27.6	3.1	0.0	0.3	0.0	0.0	3.4	0.7	0.3	1.6	0.1	25.1	4.0	0.7	5.5	0.2	0.0	1.3	0.6	7.8	2.8	0.1	3.5	1.7	0.7	4.4	4.1	1.5	0.3	0.7	1.2	0.0	1.8	0.3	5.1	0.0	0.2	5.6	0.7	2.9	0.0	1.4	10.1	7.1	9.0	0.1	0.1	8.4	0.2	0.1	0.1	0.8	1.6	2.0	1.2	2.3	3.3	20.0	1.3	6.5	1.6	12.5	0.7	0.5	14.6	0.0	6.7	8.2	8.6	0.4	0.2	0.3	0.2	1.6	0.2	1.9	1.5	0.0	0.0	0.3	3.2	0.0	2.3	3.1	2.0	1.0	0.0	0.5	3.4	2.1	0.0	0.0	0.0	0.0	0.7	0.7	9.2	5.7	85.3	16.5	5.5	7.6	8.3	5.3	9.7	4.8	17.9	14.5	0.5	30.2	3.2	37.8	24.4	12.7	5.3	1.2	34.9	2.0	1.3	1.7	9.4	3.3	5.9	3.8	0.0	2.4	3.5	6.9	26.7	0.0	3.0	0.6	1.6	13.3	14.7	0.8	7.6	10.9	1.4	5.0	0.0	12.7	18.3	3.3	8.6	14.2	1.1	2.9	0.0	13.3	1.0	3.4	1.9	5.6	1.5	24.3	27.4
TLN2	"ILWEQ, KIAA0320"	ENSG00000171914	"Talin 2"	Q9Y4G6	15	62390526-62844631	"Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.9"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 46.1;Rod photoreceptor cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.8;hTERT-HME1: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017194, HPA051828, HPA054787"	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		81000000	"Focal adhesion sites, Cytosol"		"CAB017194: , HPA051828: AB_2732570, HPA054787: AB_2732587"	"prognostic favorable (6.53e-4)"	"unprognostic (2.61e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.81e-6)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.30e-1)"	12.5	3.1	7.0	12.1	7.0	2.3	5.3	5.4	18.9	5.6	24.3	4.0	1.7	3.3	6.5	4.2	3.4	3.2	6.3	8.5	6.8	6.0	36.9	1.8	1.9	1.3	6.2	4.2	7.0	3.3	2.3	3.0	2.4	4.5	3.1	5.4	5.5	5.4	1.6	16.9	1.6	16.6	6.9	9.6	0.8	4.1	3.5	1.3	0.9	29.0	4.5	1.3	4.3	7.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.8	2.7	3.9	4.6	29.8	2.8	4.4	6.6	5.2	6.1	6.0	7.2	0.9	2.2	3.0	11.4	10.1	1.1	5.0	1.0	5.3	7.1	0.5	0.2	10.8	4.7	1.0	0.7	0.2	5.2	2.7	8.1	24.2	3.5	0.2	2.8	0.2	0.1	10.1	3.5	0.3	0.3	6.9	12.4	2.0	2.7	9.9	2.7	3.2	5.5	0.9	4.5	5.0	0.5	1.7	8.8	1.4	1.7	1.9	11.0	15.0	17.7	16.8	0.1	0.4	1.4	5.0	1.6	13.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	7.0	7.0	5.4	12.9	6.8	6.0	6.2	4.2	4.5	1.3	0.0	2.7	1.3	1.5	2.2	11.7	35.9	2.5	0.0	1.2	26.2	35.3	1.0	10.0	3.4	3.4	4.9	16.5	0.0	3.3	22.8	11.6	1.5	0.0	10.6	4.5	46.1	2.4	4.3	5.6	4.0	10.9	5.1	0.0	1.0	16.7	10.1	2.9	17.3	14.9	25.8	47.3	0.0	7.6	2.6	19.4	1.4	1.1	0.0	27.9	1.4
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362156-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	86	"intestine: 147.8"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 33.2;Enterocytes: 27.7;Late spermatids: 61.3;Paneth cells: 11.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 7.2;RPMI-8226: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	46.5	0.0	0.0	73.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.1	0.1	147.8	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	1.2	1.1	0.5	1.7	0.7	0.0	0.1	7.2	0.2	0.1	0.0	0.0	1.3	0.9	0.1	0.0	0.0	1.4	0.5	0.2	0.1	0.4	0.2	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.2	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.4	0.8	0.3	0.0	0.1	1.6	0.3	0.1	0.1	0.5	0.1	4.5	0.1	0.3	0.6	1.7	1.1	0.1	0.0	0.1	0.3	0.1	0.3	0.6	0.3	2.0	0.2	0.5	0.3	0.4	0.2	0.2	0.2	0.8	0.5	0.1	0.7	0.3	0.3	0.7	0.4	0.4	0.0	1.1	0.7	0.5	1.1	1.7	0.1	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	11.5	0.7	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.2	0.0
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1;kidney: 22.6;placenta: 28.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.5	2.2	0.9	2.8	1.9	0.0	2.1	0.6	1.6	6.3	14.7	6.0	1.5	22.7	1.6	3.5	0.4	4.6	4.8	2.3	1.6	1.1	22.6	7.8	5.5	0.1	4.2	0.7	0.9	9.6	6.4	2.0	28.0	4.8	1.6	2.9	1.4	6.1	2.2	0.1	1.1	25.1	0.4	13.4	0.8	2.0	3.0	2.1	0.1	8.8	0.4	0.7	2.1	2.4	0.5	0.3	0.9	3.2	0.0	2.0	0.4	9.7	0.7	0.1	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	2.3	18.3	0.1	12.9	0.0	0.8	8.3	0.0	4.2	0.0	0.1	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.2	0.0	0.6	0.7	0.4	0.0	0.2	0.7	0.1	0.1	0.0	32.2	2.5	0.1	0.0	0.5	11.3	0.0	0.2	31.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	3.2	0.0	0.5	1.3	0.8	0.0	0.0	1.1	0.6	0.0	0.0	2.4	0.3	2.0	0.4	0.9	1.9	0.6	1.6	1.6	1.1	4.2	0.7	4.8	2.1	14.9	5.1	0.0	2.4	0.1	0.0	2.0	35.7	2.7	5.7	48.8	0.0	26.6	29.9	42.9	12.0	0.3	54.0	0.0	4.0	4.7	0.3	0.3	0.0	13.4	1.7	0.0	3.5	1.3	0.6	8.8	0.0	0.1	5.0	1.8	4.3	8.3	23.3	23.0	0.0	67.4	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	7.4	1.2
TMEM53	"FLJ22353, NET4"	ENSG00000126106	"Transmembrane protein 53"	Q6P2H8	1	44635238-44674555	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.7;liver: 44.7"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 845.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 38.7"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 38.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021134	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Golgi apparatus"	"Focal adhesion sites"	"HPA021134: AB_2205162"	"unprognostic (5.28e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.19e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.02e-5)"	"unprognostic (1.15e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.29e-2)"	8.3	9.0	6.0	4.4	8.7	6.0	7.0	2.4	11.8	4.9	11.0	8.8	4.6	16.6	5.7	7.2	4.5	5.3	7.6	9.3	6.2	6.1	14.8	44.7	7.3	6.4	6.8	6.2	7.7	5.4	3.3	6.4	4.3	8.0	5.2	7.2	13.9	6.0	3.8	4.2	3.9	16.4	4.5	6.1	4.8	7.7	18.8	4.4	3.6	8.2	3.1	4.0	7.3	3.7	5.3	38.7	3.6	8.6	2.8	3.1	2.8	7.6	8.8	8.0	5.8	10.4	7.9	9.6	2.2	6.7	4.4	6.6	2.8	24.2	2.4	7.3	2.1	17.0	6.9	2.2	4.7	2.3	3.8	5.6	2.8	3.6	13.4	10.4	2.2	10.3	9.3	7.3	8.8	1.9	4.8	2.4	5.5	1.2	3.1	2.6	4.5	2.5	6.5	4.6	5.9	5.2	4.0	1.1	23.6	13.1	8.0	5.6	5.4	2.4	9.6	12.4	5.9	3.0	5.8	1.0	3.2	5.5	4.6	2.8	2.2	2.6	1.3	8.4	5.7	3.7	3.6	5.2	2.3	3.0	8.6	2.6	5.3	3.1	2.5	2.6	5.0	1.5	2.0	0.5	2.8	6.0	38.7	3.0	2.8	6.0	8.7	2.4	11.8	6.2	6.1	6.8	6.2	8.0	4.4	6.0	11.8	2.4	6.7	1.4	5.6	24.6	10.2	18.7	9.1	19.2	3.9	11.6	38.1	14.3	155.5	8.7	50.1	23.3	22.5	13.2	5.6	7.8	5.8	81.3	29.8	17.5	13.8	8.0	8.3	845.8	8.3	7.2	8.5	1.8	18.4	12.9	16.0	56.1	11.7	39.8	12.4	25.8	7.3	5.1	8.3	1.9	7.8	4.1	15.4	10.3
TRIM62	"DEAR1, FLJ10759"	ENSG00000116525	"Tripartite motif containing 62"	Q9BVG3	1	33145402-33182059	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 9.5;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050061			Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Vesicles, Focal adhesion sites"		"HPA050061: AB_2681001"	"unprognostic (1.57e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-3)"	4.8	11.8	10.1	6.4	19.2	9.3	6.2	19.0	13.9	5.6	4.9	31.8	1.6	5.6	4.9	6.9	6.9	5.1	4.9	5.3	12.3	10.5	5.3	2.7	5.6	9.6	28.1	9.1	6.7	4.8	7.5	9.2	19.6	15.4	8.7	5.4	5.0	10.8	7.5	6.7	20.5	5.8	6.9	12.8	8.3	6.5	4.0	23.7	8.7	6.3	5.1	10.4	9.8	7.3	3.0	1.8	6.0	3.5	1.7	8.5	2.1	2.9	2.3	20.7	3.4	5.2	2.3	6.3	2.9	8.7	5.4	4.8	2.4	3.0	4.7	3.2	2.6	2.6	6.0	4.1	3.8	5.2	4.5	3.2	5.4	2.5	1.9	5.0	1.7	13.5	4.5	3.5	7.2	1.8	8.9	5.4	4.3	0.8	3.1	5.5	7.8	5.3	1.7	4.9	3.7	2.9	6.7	10.8	2.2	3.5	7.7	5.0	3.1	3.2	12.2	13.8	12.1	3.4	1.2	5.2	2.3	3.2	6.6	2.2	5.8	2.5	2.3	4.2	3.2	2.8	2.2	2.0	6.0	2.7	3.5	4.6	2.2	4.1	3.7	1.8	3.0	2.8	2.7	4.4	1.7	2.2	0.8	8.5	2.1	10.1	19.2	19.0	13.9	12.3	10.5	28.1	9.1	15.4	23.7	3.0	2.1	0.9	0.7	2.4	2.4	0.6	0.0	0.0	0.0	1.8	0.0	0.8	0.0	1.4	0.5	1.0	1.1	0.0	1.7	1.6	1.3	2.2	1.1	0.6	1.0	9.5	1.7	1.3	1.2	0.0	2.3	1.2	0.0	1.0	2.0	1.4	2.1	0.0	4.6	0.6	0.8	6.5	2.0	1.1	0.4	4.1	1.1	1.9	0.9	1.7
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136213320-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.8;SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022592, HPA031126"	Uncertain		Uncertain	"Actin filaments,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Actin filaments"	"CAB022592: , HPA031126: AB_10603221"			"unprognostic (1.49e-1)"		"unprognostic (2.08e-1)"					"unprognostic (3.03e-2)"	"unprognostic (2.89e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.78e-2)"		0.0	2.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.2	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.4			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
USP40	FLJ10785	ENSG00000085982	"Ubiquitin specific peptidase 40"	Q9NVE5	2	233475520-233566782	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005821	Uncertain		Approved	"Vesicles,Focal adhesion sites"		NA	NA			Vesicles	"Focal adhesion sites"	"HPA005821: AB_1080526"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.53e-2)"	12.5	20.5	11.0	8.2	17.7	3.5	16.1	8.2	13.5	12.4	12.1	26.1	22.5	11.6	16.2	28.1	13.9	13.4	13.2	10.8	11.3	8.5	16.9	15.7	13.9	7.6	22.1	10.1	19.6	17.2	22.8	24.3	16.3	16.5	16.1	11.2	16.4	13.9	19.7	13.6	21.7	15.2	17.1	20.1	11.4	16.3	23.3	18.9	9.8	21.2	9.4	12.0	18.0	11.8	1.9	5.0	0.4	2.8	1.4	2.2	1.4	9.5	11.1	10.2	6.9	15.0	14.1	9.0	9.4	7.3	8.8	9.6	7.9	11.4	0.2	2.8	15.1	22.6	17.0	7.8	16.7	12.6	0.0	5.1	7.5	9.2	13.3	13.1	3.1	5.1	13.4	12.1	12.9	18.2	15.4	10.1	4.6	12.1	1.8	12.3	7.7	3.4	4.7	4.5	9.9	9.0	0.0	21.2	4.4	10.4	15.4	5.6	6.1	7.5	7.8	9.7	8.0	8.8	7.1	9.9	12.2	7.6	5.1	11.4	3.4	2.6	0.4	15.9	5.7	10.6	0.0	2.7	0.0	1.3	2.8	0.6	1.3	1.5	1.3	4.0	1.9	1.9	2.2	0.4	1.4	2.3	5.0	2.0	1.4	11.0	17.7	8.2	13.5	11.3	8.5	22.1	10.1	16.5	18.9	29.8	31.5	3.7	9.6	6.5	18.6	8.9	10.2	24.1	23.9	15.7	23.6	17.1	6.6	7.9	6.7	7.1	10.9	0.0	10.6	8.8	7.4	11.3	9.2	20.9	7.0	22.3	14.5	12.3	10.4	7.8	6.4	6.7	3.3	5.4	9.1	13.0	9.7	8.6	7.8	11.6	20.8	12.9	8.2	31.2	14.9	9.3	13.2	4.4	11.2	7.1
ZBTB8A	"BOZF1, FLJ90065, ZBTB8, ZNF916A"	ENSG00000160062	"Zinc finger and BTB domain containing 8A"	Q96BR9	1	32539427-32605939	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 33.2;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031768, HPA031769, HPA031770"	Approved		Approved	"Nuclear speckles,Focal adhesion sites"		NA	NA			"Nuclear speckles, Focal adhesion sites"		"HPA031768: AB_10610568, HPA031769: AB_2674036, HPA031770: AB_2674037"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.45e-5)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.15e-2)"	8.8	4.9	4.4	3.2	5.0	2.3	19.1	11.1	5.9	13.6	6.2	4.8	12.2	3.8	12.7	8.6	7.2	7.8	5.7	6.9	4.4	3.4	5.7	4.4	14.0	1.9	3.3	4.5	8.6	10.9	10.7	8.9	5.5	7.9	7.8	6.2	6.9	9.9	11.4	10.3	4.8	4.2	15.4	5.2	2.7	6.4	6.2	3.5	1.8	11.2	6.6	3.0	9.1	7.6	1.6	2.1	4.1	1.0	2.6	1.0	0.5	6.6	1.9	7.8	8.4	5.6	7.5	5.9	6.7	5.3	6.3	6.4	0.8	5.4	5.4	4.6	7.2	2.8	5.2	7.7	5.3	5.6	1.4	5.2	0.3	6.6	2.9	7.2	1.2	0.4	5.0	7.6	4.6	12.1	6.3	7.0	4.9	1.1	3.9	6.3	6.8	3.6	0.6	7.1	3.3	2.8	6.6	11.4	4.3	3.9	6.9	6.6	6.0	9.3	4.7	8.9	4.3	6.1	3.1	7.2	8.4	6.9	11.5	4.8	7.1	3.4	4.2	5.8	1.4	3.5	4.1	1.0	0.8	0.8	0.6	1.0	0.8	0.7	0.7	0.7	1.6	0.8	0.9	3.8	2.6	0.8	2.1	0.6	0.5	4.4	5.0	11.1	5.9	4.4	3.4	3.3	4.5	7.9	3.5	14.9	14.4	1.5	6.3	3.7	10.5	3.6	5.1	4.0	4.5	7.0	21.6	2.5	1.7	5.7	3.8	12.8	3.5	0.0	4.5	5.1	10.1	7.2	2.3	3.6	1.4	6.4	4.7	20.3	4.0	3.9	18.4	4.8	3.3	1.0	4.5	4.1	5.0	3.5	33.2	2.4	8.7	32.3	11.3	0.9	4.3	3.3	1.3	2.5	8.7	5.4